Refine publication list

Chart

 to  

• English (246)
• German (36)

• Muley, Thomas (70)
• Christopoulos, Petros (70)
• Stenzinger, Albrecht (61)
• Herth, Felix (52)
• Meister, Michael (50)
• Heußel, Claus Peter (41)
• Bozorgmehr, Farastuk (36)

• Warth, Arne (35)
• Schirmacher, Peter (34)
• Winter, Hauke (34)
• Schneider, Marc (28)
• Debus, Jürgen (27)
• Kazdal, Daniel (27)
• Kriegsmann, Mark (25)
• Villalobos Bollen, Matthias Americo (24)
• Kirchner, Martina (23)
• Rieken, Stefan (22)
• Volckmar, Anna-Lena (22)
• Penzel, Roland (21)
• Budczies, Jan (21)
• Endris, Volker (20)
• Allgäuer, Michael (20)
• Steins, Martin (20)
• Schnabel, Philipp Albert (1953-2021) (19)
• Dienemann, Hendrik (19)
• Hoffmann, Hans (19)
• Hörner-Rieber, Juliane (19)
• Bischoff, Helge (19)
• Sültmann, Holger (17)
• El-Shafie, Rami (16)
• König, Laila (15)
• Krisam, Johannes (14)
• Herpel, Esther (14)
• Adeberg, Sebastian (13)
• Reinmuth, Niels (13)
• Eichhorn, Martin E. (13)
• Kappes, Jutta (12)
• Siegle, Anja (12)
• Kuon, Jonas (12)
• Fröhling, Stefan (12)
• (further entries exist...)

• Griesinger, Frank (21)
• Eberhardt, Wilfried E. E. (7)
• Sebastian, Martin (7)
• Reck, Martin (6)
• Schütte, Wolfgang (5)
• Huber, Rudolf M. (5)
• Montag, Thomas (4)

• Serke, Monika (4)
• Thatcher, Nicholas (3)
• Kuhnt, Thomas (3)
• Schwartz, Jacqueline (3)
• Wolf, Carolin (3)
• Gärtner, Jan (3)
• van Oorschot, Birgitt (3)
• Mehnert, Anja (3)
• Goldmann, Torsten (3)
• Vogt, Jeannette (3)
• Lordick, Florian (3)
• Besse, Benjamin (3)
• Socinski, Mark A. (3)
• Pérol, Maurice (3)
• Shaw, Alice T. (3)
• Kim, Dong-Wan (3)
• Felip, Enriqueta (3)
• Hipper, Annette (3)
• Fleitz, Annette (3)
• Lin, Huamao M. (3)
• Hong, Jin-Liern (3)
• Geißler, Michael (2)
• Vincent, Sylvie (2)
• Scagliotti, Giorgio V. (2)
• Garon, Edward B. (2)
• Marien, Eyra (2)
• Nauck, Friedemann (2)
• Wermke, Martin (2)
• Jentschke, Elisabeth (2)
• Viehrig, Marén (2)
• Simon, Steffen (2)
• Thuss-Patience, Peter (2)
• Seeger, Werner (2)
• (further entries exist...)

Publications in heiBIB     

• Cho, Byoung C.: Amivantamab plus lazertinib in previously untreated EGFR-mutated advanced NSCLC / B.C. Cho, S. Lu, E. Felip, A.I. Spira, N.Girard, J.-S. Lee, S.-H. Lee, Y. Ostapenko, P. Danchaivijit… , June 26, 2024. - 13 S. : Illustrationen
  In: The New England journal of medicine, ISSN 1533-4406. 391(2024), 16 vom: Okt., Seite 1486-1498
  DOI: 10.1056/NEJMoa2403614
• Montag, Thomas: SOP - Behandlung und Betreuung in der Sterbephase / Thomas Montag, Michael Thomas, Thomas Kramer, Steffen Simon, December 2024. - 5 S.
  In: Die Onkologie, ISSN 2731-7234. 30(2024), Suppl 2 vom: Dez., Seite 1156-1160
  DOI: 10.1007/s00761-024-01594-z
• Bischoff, Philip: Outcome of first-line treatment with pembrolizumab according to KRAS/TP53 mutational status for nonsquamous programmed death-ligand 1-High (≥50%) NSCLC in the German national network genomic medicine lung cancer / Philip Bischoff, MD, Martin Reck, MD, Tobias Overbeck, MD, Petros Christopoulos, MD, Julia Röper, Ph… , May 2024. - 15 S. : Illustrationen
  In: Journal of thoracic oncology, ISSN 1556-1380. 19(2024), 5, Artikel-ID 5, Seite 803-817
  DOI: 10.1016/j.jtho.2023.12.015
• Richtmann, Sarah: The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancer / Sarah Richtmann, Sebastian Marwitz, Thomas Muley, Hannu Koistinen, Petros Christopoulos, Michael Tho… , October 2024. - 13 S. : Illustrationen
  In: Translational research, ISSN 1878-1810. 272(2024) vom: Okt., Seite 177-189
  DOI: 10.1016/j.trsl.2024.02.007
• Unsöld, Laura: "There is no alternative." : Treatment decision-making in lung cancer patients with limited prognosis : results of a qualitative interview study / Laura Unsöld, Nicole Deis, Anja Siegle, Michael Thomas, and Matthias Villalobos, 05 September 2024. - 8 S.
  In: European journal of cancer care, ISSN 1365-2354. 2024(2024), 1, Artikel-ID 8889981, Seite 1-8
  DOI: 10.1155/2024/8889981
• König, Mara: Personal values, wishes, and goals of patients with advanced lung cancer : a qualitative study / Mara König, Anja Siegle, Laura Unsöld, Jan Ole Ludwig, Nicole Deis, Michael Thomas, Regina Poß-Doeri… , 2024. - 11 S.
  In: European journal of cancer care, ISSN 1365-2354. 33(2024), 1, Artikel-ID 9987322, Seite 1-11
  DOI: 10.1155/2024/9987322
• Hahnemann, Laura: Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases : clinical outcome and prognostic factors / L. Hahnemann, A. Krämer, C. Fink, C. Jungk, M. Thomas, P. Christopoulos, J. W. Lischalk, J. Meis, J.… , 21 April 2024. - 10 S.
  In: Clinical and translational radiation oncology, ISSN 2405-6308. 46(2024), Artikel-ID 100782, Seite 100782-1-100782-10
  DOI: 10.1016/j.ctro.2024.100782
• Rieckmann, Lisa-Marie: Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells / Lisa-Marie Rieckmann, Michael Spohn, Lisa Ruff, David Agorku, Lisa Becker, Alina Borchers, Jenny Kra… , 08 May 2024. - 9 S.
  In: Molecular cancer, ISSN 1476-4598. 23(2024), 1, Seite 1-9
  DOI: 10.1186/s12943-024-01984-2
• Budczies, Jan: KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma / Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Raj… , 12 June 2024. - 10 S. : Illustrationen
  In: British journal of cancer, ISSN 1532-1827. 131(2024), 3, Seite 524-533
  DOI: 10.1038/s41416-024-02746-z
• Alashkar Alhamwe, Bilal: Peripheral inflammation featuring eosinophilia or neutrophilia is associated with the survival and infiltration of eosinophils within the tumor among various histological subgroups of patients with NSCLC / Bilal Alashkar Alhamwe, Kadriya Yuskaeva, Friederike Wulf, Frederik Trinkmann, Mark Kriegsmann, Mich… , 3 September 2024. - 16 S.
  In: International journal of molecular sciences, ISSN 1422-0067. 25(2024), 17, Artikel-ID 9552, Seite 1-16
  DOI: 10.3390/ijms25179552
• Houda, Ilias: Challenges and controversies in resectable non-small cell lung cancer : a clinician’s perspective / Ilias Houda, Chris Dickhoff, Carin A. Uyl-de Groot, Ronald A. M. Damhuis, Noemi Reguart, Mariano Pro… , March 2024. - 8 S.
  (Advancements in non-small cell lung cancer)
  In: The lancet, ISSN 2666-7762. 38(2024) vom: März, Artikel-ID 100841, Seite 1-8
  DOI: 10.1016/j.lanepe.2024.100841
• Montag, Thomas: SOP - Behandlung und Betreuung in der Sterbephase / Thomas Montag, Michael Thomas, Thomas Kramer, Steffen Simon, March 2024. - 4 S. : Illustrationen
  In: Die Onkologie, ISSN 2731-7234. 30(2024), 2, Suppl. 2 vom: März, Seite 94-97
  DOI: 10.1007/s00761-022-01180-1
• Eschbach, Corinna: SOP - Inappetenz und Kachexie / C. Eschbach, M. Villalobos, C. Wolf, M. Thomas, March 2024. - 7 S.
  In: Die Onkologie, ISSN 2731-7234. 30(2024), 2, Suppl. 2 vom: März, Seite 87-93
  DOI: 10.1007/s00761-022-01179-8
• Besse, Benjamin: Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer : a phase 2 umbrella trial / Benjamin Besse, Elvire Pons-Tostivint, Keunchil Park, Sylvia Hartl, Patrick M. Forde, Maximilian J. … , 13 February 2024. - 32 S.
  In: Nature medicine, ISSN 1546-170X. 30(2024), 3, Seite 716-729, [1-19]
  DOI: 10.1038/s41591-024-02808-y
• Sebastian, Martin: Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic : real-world data from the German prospective CRISP Registry (AIO-TRK-0315) / Martin Sebastian, Wilfried E. E. Eberhardt, Eyck von der Heyde, Steffen Dörfel, Jörg Wiegand, Clemen… , 1 June 2024. - 12 S. : Illustrationen
  In: International journal of cancer, ISSN 1097-0215. 154(2024), 11 vom: Juni, Seite 1967-1978
  DOI: 10.1002/ijc.34868
• Menzel, Michael: Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors / Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Michael Allgäuer, Christin… , March 2024. - 10 S. : Illustrationen
  In: The journal of pathology: clinical research, ISSN 2056-4538. 10(2024), 2 vom: März, Artikel-ID e354, Seite 1-10
  DOI: 10.1002/cjp2.354
• Longuespée, Rémi: Therapeutic drug monitoring of osimertinib in non-small cell lung cancer and short bowel syndrome : a case report / Rémi Longuespée, Julia Kunz, Margaux Fresnais, Kathrin I. Foerster, Jürgen Burhenne, Michael Thomas,… , January 2024. - 6 S.
  In: British journal of clinical pharmacology, ISSN 1365-2125. 90(2024), 1, Seite 344-349
  DOI: 10.1111/bcp.15924
• Bozorgmehr, Farastuk: Correction : Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy$dstudy protocol of the TRADE-hypo trial / Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brück… , 10 August 2023. - 1 S.
  In: BMC cancer, ISSN 1471-2407. 23(2023), 1 vom: Aug., Artikel-ID 740, Seite 1
  DOI: 10.1186/s12885-023-11270-x
• Fink, Christoph Andreas: Comorbidity in limited disease small-cell lung cancer : age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy / Christoph A. Fink, Fabian Weykamp, Sebastian Adeberg, Farastuk Bozorgmehr, Petros Christopoulos, Kri… , 24 July 2023. - 7 S. : Illustrationen
  In: Clinical and translational radiation oncology, ISSN 2405-6308. 42(2023) vom: Sept., Artikel-ID 100665, Seite 1-7
  DOI: 10.1016/j.ctro.2023.100665
• Ou, Sai-Hong: Response to “NGS, the New Global Standard?” : Letters to the editor / Sai-Hong Ignatius Ou, MD, PhD, Jin-Liern Hong, PhD, Petros Christopoulos, MD, PhD, Huamao M. Lin, Ph… , October 2023. - 2 S.
  In: Journal of thoracic oncology, ISSN 1556-1380. 18(2023), 10, Seite e116-e118
  DOI: 10.1016/j.jtho.2023.07.022
• Blasi, Miriam: Pembrolizumab alone or with chemotherapy for 70+ year-old lung cancer patients : a retrospective study / Miriam Blasi, Jonas Kuon, Rajiv Shah, Farastuk Bozorgmehr, Florian Eichhorn, Stephan Liersch, Albrec… , November 2023. - 9 S.
  In: Clinical lung cancer, ISSN 1938-0690. 24(2023), 7 vom: Nov., Seite e282-e290
  DOI: 10.1016/j.cllc.2023.06.010
• Mazieres, Julien: Tepotinib treatment in patients with MET exon 14-skipping non-small cell lung cancer : long-term follow-up of the VISION phase 2 nonrandomized clinical trial / Julien Mazieres, MD, PhD; Paul K. Paik, MD; Marina C. Garassino, MD; Xiuning Le, MD; Hiroshi Sakai, … , June 4, 2023. - 7 S.
  In: JAMA oncology, ISSN 2374-2445. 9(2023), 9 vom: Sept., Seite 1260-1266
  DOI: 10.1001/jamaoncol.2023.1962
• Frost, Nikolaj: Rationale and design of the phase II ANTELOPE study of atezolizumab, carboplatin and nab-Paclitaxel vs. pembrolizumab, platinum and pemetrexed in TTF-1 negative, metastatic lung adenocarcinoma (AIO-TRK-0122) / Nikolaj Frost, Annalen Bleckmann, Frank Griesinger, Christian Grohé, Melanie Janning, Jens Kollmeier… , September 2023. - 5 S.
  In: Clinical lung cancer, ISSN 1938-0690. 24(2023), 6 vom: Sept., Seite 568-572
  DOI: 10.1016/j.cllc.2023.04.009
• Şeker-Cin, Huriye: Analysis of rare fusions in NSCLC : genomic architecture and clinical implications / Huriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, Klaus Kluck, Markus Ball, Olaf Neumann, Hau… , October 2023. - 14 S.
  In: Lung cancer, ISSN 1872-8332. 184(2023) vom: Okt., Artikel-ID 107317, Seite 1-14
  DOI: 10.1016/j.lungcan.2023.107317
• Goldschmid, Hannah: Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas / Hannah Goldschmid, Klaus Kluck, Markus Ball, Martina Kirchner, Michael Allgäuer, Hauke Winter, Felix… , June 2023. - 9 S. : Illustrationen
  In: Lung cancer, ISSN 1872-8332. 180(2023) vom: Juni, Artikel-ID 107212, Seite 1-9
  DOI: 10.1016/j.lungcan.2023.107212
• Ou, Sai-Hong: Distribution and detectability of EGFR exon 20 insertion variants in NSCLC / Sai-Hong Ignatius Ou, MD, PhD, Jin-Liern Hong, PhD, Petros Christopoulos, MD, PhD, Huamao M. Lin, Ph… , June 2023. - 11 S. : Illustrationen
  In: Journal of thoracic oncology, ISSN 1556-1380. 18(2023), 6 vom: Juni, Seite 744-754
  DOI: 10.1016/j.jtho.2023.01.086
• Deis, Nicole: HELP - Heidelberg decision aid for lung cancer patients : a randomized controlled clinical trial / Nicole Deis, Laura Unsöld, Anja Siegle, Johannes Krisam, Michael Thomas and Matthias Villalobos, 25 May 2023. - 13 S.
  In: Trials, ISSN 1468-6694. 24(2023), Artikel-ID 356, Seite 1-13
  DOI: 10.1186/s13063-023-07365-2
• Christopoulos, Petros: Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations / Petros Christopoulos, Thibaud Prawitz, Jin-Liern Hong, Huamao M. Lin, Luis Hernandez, Shu Jin, Min T… , 13 April 2023. - 7 S.
  In: Lung cancer, ISSN 1872-8332. 179(2023) vom: Apr., Artikel-ID 107191, Seite 1-7
  DOI: 10.1016/j.lungcan.2023.107191
• Regnery, Sebastian: To fly or not to fly : stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes / Sebastian Regnery, Efthimios Katsigiannopulos, Philipp Hoegen, Fabian Weykamp, Elisabetta Sandrini, … , 23 March 2023. - 8 S.
  In: Lung cancer, ISSN 1872-8332. 179(2023) vom: März, Artikel-ID 107175, Seite 1-8
  DOI: 10.1016/j.lungcan.2023.03.011
• Metzenmacher, Martin: Prognostic factors in nonsmall cell lung cancer : insights from the German CRISP registry / Martin Metzenmacher, Frank Griesinger, Horst-Dieter Hummel, Corinna Elender, Harald Schäfer, Maike d… , February 2, 2023. - 16 S.
  In: The European respiratory journal, ISSN 1399-3003. 61(2023), 2, Artikel-ID 2201336, Seite 1-16
  DOI: 10.1183/13993003.01336-2022
• Solar, Stefanie: Screening versus multidimensional assessment of symptoms and psychosocial distress in cancer patients from the time of incurability / Stefanie Solar, Johannes Wieditz, Florian Lordick, Anja Mehnert-Theuerkauf, Karin Oechsle, Birgitt v… , 26 January 2023. - 10 S.
  In: Frontiers in oncology, ISSN 2234-943X. 13(2023) vom: Jan., Artikel-ID 1002499, Seite 1-10
  DOI: 10.3389/fonc.2023.1002499
• Siegle, Anja: Communication with patients with limited prognosis : an integrative mixed-methods evaluation study / Anja Siegle, Laura Unsöld, Nicole Deis, Katja Krug, Jasmin Bossert, Johannes Krisam, Corinna Jung, J… , 2023. - 10 S.
  In: Supportive care in cancer, ISSN 1433-7339. 31(2023), 1, Artikel-ID 77, Seite 1-10
  DOI: 10.1007/s00520-022-07474-9
• Eichkorn, Tanja: High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes / Tanja Eichkorn, Jonathan W. Lischalk, Cedric Stüwe, Eric Tonndorf-Martini, Kai Schubert, Lisa-Antoni… , 13 January 2023. - 14 S.
  In: Frontiers in oncology, ISSN 2234-943X. 12(2023) vom: Jan., Artikel-ID 1035370, Seite 1-14
  DOI: 10.3389/fonc.2022.1035370
• Kuon, Jonas: Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer : a multicenter, longitudinal, prospective cohort study / Jonas Kuon, Miriam Blasi, Laura Unsöld, Jeannette Vogt, Anja Mehnert, Bernd Alt-Epping, Birgitt van … , 7 December 2021. - 10 S.
  In: European radiology, ISSN 1432-1084. 30(2022), 4, Seite 3131-3140
  DOI: 10.1007/s00520-021-06736-2
• Janke, Florian: Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients / Florian Janke, Arlou Kristina Angeles, Anja Lisa Riediger, Simone Bauer, Martin Reck, Albrecht Stenz… , 02 December 2022. - 15 S. : Illustrationen
  In: Clinical epigenetics, ISSN 1868-7083. 14(2022), Artikel-ID 163, Seite 1-15
  DOI: 10.1186/s13148-022-01387-4
• Rheinheimer, Stephan: Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification : higher contrast uptake associated with response and better prognosis / Stephan Rheinheimer, Petros Christopoulos, Stella Erdmann, Julia Saupe, Heiko Golpon, Jens Vogel-Cla… , 05 December 2022. - 12 S. : Illustrationen
  In: BMC medical imaging, ISSN 1471-2342. 22(2022), Artikel-ID 215, Seite 1-12
  DOI: 10.1186/s12880-022-00943-x
• Le, Xiuning: Tepotinib efficacy and safety in patients with met exon 14 skipping nsclc : outcomes in patient subgroups from the vision study with relevance for clinical practice / Xiuning Le, Hiroshi Sakai, Enriqueta Felip, Michael Thomas, Frank Griesinger [und viele weitere], March 15 2022. - 10 S.
  In: Clinical cancer research, ISSN 1557-3265. 28(2022), 6, Seite 1117-1126
  DOI: 10.1158/1078-0432.CCR-21-2733
• Chouaid, Christos: Effectiveness of Nivolumab in second-line and later in patients with advanced non-small cell lung cancer in real-life practice in France and Germany : analysis of the ESME-AMLC and CRISP cohorts / Christos Chouaid, Michael Thomas, Didier Debieuvre, Isabelle Durand-Zaleski, Stefan Zacharias, Lise … , 13 December 2022. - 20 S.
  In: Cancers, ISSN 2072-6694. 14(2022), 24 vom: Dez., Artikel-ID 6148, Seite 1-20
  DOI: 10.3390/cancers14246148
• Griesinger, Frank: Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy : update from the ARROW trial / F. Griesinger, G. Curigliano, M. Thomas, V. Subbiah, C.S. Baik, D.S.W. Tan, D.H. Lee, D. Misch, E. G… , 13 August 2022. - 11 S.
  In: Annals of oncology, ISSN 1569-8041. 33(2022), 11 vom: Nov., Seite 1168-1178
  DOI: 10.1016/j.annonc.2022.08.002
• Griesinger, Frank: Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany / Frank Griesinger, Maurice Pérol, Nicolas Girard, Isabelle Durand-Zaleski, Stefan Zacharias, Lise Bos… , 6 August 2022. - 10 S.
  In: Lung cancer, ISSN 1872-8332. 172(2022) vom: Okt., Seite 65-74
  DOI: 10.1016/j.lungcan.2022.08.001
• Schindler, Hannah: Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors / Hannah Schindler, Fabienne Lusky, Lea Daniello, Mariam Elshiaty, Lena Gaissmaier, Karolina Benesova,… , 31 October 2022. - 16 S.
  In: Frontiers in oncology, ISSN 2234-943X. 12(2022) vom: Okt., Artikel-ID 1010660, Seite 1-16
  DOI: 10.3389/fonc.2022.1010660
• Schwartz, Jacqueline: Depression in der Palliativmedizin / Jacqueline Schwartz, Martin Neukirchen, Beate Hornemann, Jan Gärtner, Carolin Wolf, Michael Thomas, 09 June 2022. - 6 S.
  In: Die Onkologie, ISSN 2731-7234. 28(2022), 10, Seite 931-936
  DOI: 10.1007/s00761-022-01182-z
• Faltus, Christian: Identification of NHLRC1 as a novel AKT activator from a lung cancer epigenome-wide association study (EWAS) / Christian Faltus, Angelika Lahnsteiner, Myrto Barrdahl, Yassen Assenov, Anika Hüsing, Olga Bogatyrov… , 14 September 2022. - 18 S.
  In: International journal of molecular sciences, ISSN 1422-0067. 23(2022), 18, Artikel-ID 10699, Seite 1-18
  DOI: 10.3390/ijms231810699
• Bozorgmehr, Farastuk: Protocol of the TREASURE study : Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease$da randomized, open-label, multicenter phase II trial / Farastuk Bozorgmehr, Petros Christopoulos, Inn Chung, Jelena Cvetkovic, Manuel Feißt, Johannes Krisa… , 24 September 2022. - 9 S.
  In: BMC cancer, ISSN 1471-2407. 22(2022), Artikel-ID 1011, Seite 1-9
  DOI: 10.1186/s12885-022-10074-9
• Rajakumar, Timothy: A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy / Timothy Rajakumar, Rastislav Horos, Julia Jehn, Judith Schenz, Thomas Muley, Oana Pelea, Sarah Hofma… , 31 March 2022. - 13 S.
  In: npj precision oncology, ISSN 2397-768X. 6(2022), Artikel-ID 19, Seite 1-13
  DOI: 10.1038/s41698-022-00262-y
• Christopoulos, Petros: The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions / Petros Christopoulos, Klaus Kluck, Martina Kirchner, Heike Lüders, Julia Roeper, Roger-Fei Falkenste… , 20 May 2022. - 13 S.
  In: European journal of cancer, ISSN 1879-0852. 170(2022) vom: Juli, Seite 106-118
  DOI: 10.1016/j.ejca.2022.04.020
• Blasi, Miriam: Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older : a propensity score-matched analysis / Miriam Blasi, Martin E. Eichhorn, Petros Christopoulos, Hauke Winter, Claus Peter Heußel, Felix J. H… , 28 June 2022. - 8 S.
  In: BMC pulmonary medicine, ISSN 1471-2466. 22(2022), Artikel-ID 255, Seite 1-8
  DOI: 10.1186/s12890-022-02043-6
• Tan, Daniel S.-W.: Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study / D. S-W. Tan, M. Thomas, D-W. Kim, S. Szpakowski, P. Urban, R. Mehra, L.Q.M. Chow, S. Sharma, B.J. So… , 2022. - 7 S.
  In: Lung cancer, ISSN 1872-8332. 163(2022), Seite 7-13
  DOI: 10.1016/j.lungcan.2021.11.007
• Boch, Tobias: Pathologic responses in oligometastatic NSCLC patients treated with neoadjuvant immune checkpoint blockade with and without chemotherapy followed by surgery / Tobias Boch, Nikolaj Frost, Linna Sommer, Tobias R. Overbeck, Christoph T. Michaeli, Chrisoph J. Szu… , 2022. - 6 S.
  In: Lung cancer, ISSN 1872-8332. 164(2022), Seite 46-51
  DOI: 10.1016/j.lungcan.2021.11.009
• Schulte-Vieting, Tamara: Developing a question prompt list for the oncology setting : a scoping review / Tamara Schulte-Vieting, Anja Siegle, Corinna Jung, Matthias Villalobos, Michael Thomas, 10 June 2022. - 14 S.
  In: Patient education and counseling, ISSN 1873-5134. 105(2022), 7, Seite 1689-1702
  DOI: 10.1016/j.pec.2021.10.006
• Kunz, Julia: Early development of ubiquitous acanthocytosis and extravascular hemolysis in lung cancer patients receiving alectinib / Julia Kunz, Christiane Wiedemann, Heidrun Grosch, Katharina Kriegsmann, Stefanie Gryzik, Julia Felde… , 31 May 2022. - 13 S.
  In: Cancers, ISSN 2072-6694. 14(2022), 11, Artikel-ID 2720, Seite 1-13
  DOI: 10.3390/cancers14112720
• Yaung, Stephanie: Early assessment of chemotherapy response in advanced non-small cell lung cancer with circulating tumor DNA / Stephanie J. Yaung, Corinna Woestmann, Christine Ju, Xiaoju Max Ma, Sandeep Gattam, Yiyong Zhou, Liu… , 2022. - 14 S.
  In: Cancers, ISSN 2072-6694. 14(2022), 10, Artikel-ID 2479, Seite 1-14
  DOI: 10.3390/cancers14102479
• Krug, Katja: Factors related to implementation of an interprofessional communication concept in thoracic oncology : a mixed-methods study / Katja Krug, Jasmin Bossert, Sophia Möllinger, Nicole Deis, Laura Unsöld, Anja Siegle, Matthias Villa… , 26 May 2022. - 10 S.
  In: BMC palliative care, ISSN 1472-684X. 21(2022), Artikel-ID 89, Seite 1-10
  DOI: 10.1186/s12904-022-00977-6
• Regnery, Sebastian: Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations / Sebastian Regnery, Carolin Buchele, Fabian Weykamp, Moritz Pohl, Philipp Hoegen, Tanja Eichkorn, Tho… , 2022. - 10 S.
  In: Frontiers in oncology, ISSN 2234-943X. 11(2022) vom: 11. Jan., Artikel-ID 757031, Seite 1-10
  DOI: 10.3389/fonc.2021.757031
• Roeper, Julia: TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy : EGFR mutated non-small cell lung cancer IV patients treated with osimertinib / Julia Roeper, Petros Christopoulos, Markus Falk, Lukas C. Heukamp, Markus Tiemann, Albrecht Stenzing… , January 2022. - 13 S.
  In: Translational Lung Cancer Research, ISSN 2226-4477. 11(2022), 1, Seite 4-16
  DOI: 10.21037/tlcr-21-754
• Krug, Katja: Effects of an interprofessional communication approach on support needs, quality of life, and mood of patients with advanced lung cancer : a randomized trial / Katja Krug, Jasmin Bossert, Nicole Deis, Johannes Krisam, Matthias Villalobos, Anja Siegle, Corinna … , 2021. - 15 S.
  In: The oncologist, ISSN 1549-490X. 26(2021), 8 vom: Aug., Seite e1445-e1459
  DOI: 10.1002/onco.13790
• Budczies, Jan: Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma / Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Krie… , 14 June 2021. - 15 S.
  In: Cancer immunology immunotherapy, ISSN 1432-0851. 71(2022), 2, Seite 251-265
  DOI: 10.1007/s00262-021-02981-w
• Regnery, Sebastian: Safety and efficacy of stereotactic body radiotherapy in ultracentral lung tumors using a risk-optimized fractionation scheme / Sebastian Regnery, Tanja Eichkorn, Fabian Weykamp, Thomas Held, Katharina Weusthof, Lisa-Antonia Din… , July 2021. - 9 S.
  In: Clinical lung cancer, ISSN 1938-0690. 22(2021), 4, Seite 332-340.e3
  DOI: 10.1016/j.cllc.2020.11.003
• Kirchner, Martina: The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma / M. Kirchner, K. Kluck, R. Brandt, A.-L. Volckmar, R. Penzel, D. Kazdal, V. Endris, O. Neumann, H. Se… , 3 September 2021. - 12 S.
  In: ESMO open, ISSN 2059-7029. 6(2021), 5, Artikel-ID 100253, Seite 1-12
  DOI: 10.1016/j.esmoop.2021.100253
• Mountzios, Giannis: Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer / G. Mountzios, E. Samantas, K. Senghas, E. Zervas, J. Krisam, K. Samitas, F. Bozorgmehr, J. Kuon, S. … , 1 September 2021. - 10 S.
  In: ESMO open, ISSN 2059-7029. 6(2021), 5, Artikel-ID 100254, Seite 1-10
  DOI: 10.1016/j.esmoop.2021.100254
• Kazdal, Daniel: Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma / Daniel Kazdal, Eugen Rempel, Cristiano Oliveira, Michael Allgäuer, Alexander Harms, Kerstin Singer, … , April 2021. - 15 S.
  In: Translational Lung Cancer Research, ISSN 2226-4477. 10(2021), Artikel-ID 4, Seite 1-15
  DOI: 10.21037/tlcr-20-1168
• Saalfeld, Felix: Efficacy of immune checkpoint inhibitors alone or in combination with chemotherapy in NSCLC harboring ERBB2 mutations / Felix C. Saalfeld, Carina Wenzel, Petros Christopoulos, Sabine Merkelbach-Bruse, Timm M. Reissig, Si… , 8 July 2021. - 7 S.
  In: Journal of thoracic oncology, ISSN 1556-1380. 16(2021), 11, Seite 1952-1958
  DOI: 10.1016/j.jtho.2021.06.025
• Angeles, Arlou Kristina J.: Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis / Arlou Kristina Angeles, Petros Christopoulos, Zhao Yuan, Simone Bauer, Florian Janke, Simon John Ogr… , 07 December 2021. - 12 S.
  In: npj precision oncology, ISSN 2397-768X. 5(2021), Artikel-ID 100, Seite 1-12
  DOI: 10.1038/s41698-021-00239-3
• Christopoulos, Petros: Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping : study protocol of the ABP trial / Petros Christopoulos, Farastuk Bozorgmehr, Lena Brückner, Inn Chung, Johannes Krisam, Marc A. Schnei… , 28 June 2021. - 10 S.
  In: BMC cancer, ISSN 1471-2407. 21(2021), Artikel-ID 743, Seite 1-10
  DOI: 10.1186/s12885-021-08460-w
• Krug, Katja: Consideration of sense of coherence in a structured communication approach with stage IV lung cancer patients and their informal caregivers : a qualitative interview study / Katja Krug, Jasmin Bossert, Lydia Stooß, Anja Siegle, Matthias Villalobos, Laura Hagelskamp, Corinna… , 2021. - 7 S.
  In: Supportive care in cancer, ISSN 1433-7339. 29(2021), 4, Seite 2153-2159
  DOI: 10.1007/s00520-020-05724-2
• Gainor, Justin: Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW) : a multi-cohort, open-label, phase 1/2 study / Justin F. Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S. Baik, … , June 9, 2021. - 11 S.
  In: The lancet, ISSN 1474-5488. 22(2021), 7, Seite 959-969
  DOI: 10.1016/S1470-2045(21)00247-3
• Christopoulos, Petros: Earlier extracranial progression and shorter survival in ALK- rearranged lung cancer with positive liquid rebiopsies / Petros Christopoulos, Steffen Dietz, Arlou K. Angeles, Stephan Rheinheimer, Daniel Kazdal, Anna-Lena… , 2021. - 14 S.
  In: Translational Lung Cancer Research, ISSN 2226-4477. 10(2021), 5 vom: Mai, Seite 2118-2131
  DOI: 10.21037/tlcr-21-32
• Hohmann, Nicolas: Pharmacoenhancement of low crizotinib plasma concentrations in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer using the CYP3A inhibitor cobicistat / Nicolas Hohmann, Farastuk Bozorgmehr, Petros Christopoulos, Gerd Mikus, Antje Blank, Jürgen Burhenne… , 2021. - 5 S.
  In: Clinical and translational science, ISSN 1752-8062. 14(2021), 2, Seite 487-491
  DOI: 10.1111/cts.12921
• El-Shafie, Rami: Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer / R.A. El Shafie, K. Seidensaal, F. Bozorgmehr, D. Kazdal, T. Eichkorn, M. Elshiaty, D. Weber, M. Allg… , 2 June 2021. - 10 S.
  In: ESMO open, ISSN 2059-7029. 6(2021), 3, Artikel-ID 100161, Seite 1-10
  DOI: 10.1016/j.esmoop.2021.100161
• Daniello, Lea: Therapeutic and prognostic implications of immune-related adverse events in advanced non-small-cell lung cancer / Lea Daniello, Mariam Elshiaty, Farastuk Bozorgmehr, Jonas Kuon, Daniel Kazdal, Hannah Schindler, Raj… , 29 June 2021. - 14 S.
  In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 29. Juni, Artikel-ID 703893, Seite 1-14
  DOI: 10.3389/fonc.2021.703893
• Griesinger, Frank: Corrigendum to “Biomarker testing in non-small cell lung cancer in routine care : Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)” [Lung Cancer 152 (2021) 174-184] / Frank Griesinger, Wilfried Eberhardt, Arnd Nusch, Marcel Reiser, Mark-Oliver Zahn, Christoph Maintz,… , 26 May 2021. - 1 S.
  In: Lung cancer, ISSN 1872-8332. 157(2021) vom: Juli, Seite 167
  DOI: 10.1016/j.lungcan.2021.05.005
• Griesinger, Frank: Biomarker-stratifizierte Therapie des nichtkleinzelligen Lungenkarzinoms : wann sollten die Tests erfolgen? / Frank Griesinger, Michael Thomas, 14 April 2021. - 3 S.
  In: Deutsche medizinische Wochenschrift, ISSN 1439-4413. 146(2021), 8, Seite 559-561
  DOI: 10.1055/a-1383-5231
• Kriegsmann, Katharina: Role of synaptophysin, chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation : a retrospective large-scale study on 1170 tissue samples / Katharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, Petros Christopoulos, Michael Thomas, Hau… , 01 May 2021. - 9 S.
  In: BMC cancer, ISSN 1471-2407. 21(2021), Artikel-ID 486, Seite 1-9
  DOI: 10.1186/s12885-021-08140-9
• Magios, Nikolaus: Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer / Nikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, Daniel Kazdal, Martina Kirchner, Felix J. … , March 24, 2021. - 13 S.
  In: Therapeutic advances in medical oncology, ISSN 1758-8359. 13(2021) vom: Jan., Artikel-ID 1758835921996509, Seite 1-13
  DOI: 10.1177/1758835921996509
• Sebastian, Martin: KRAS G12C-mutated advanced non-small cell lung cancer : a real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315) / Martin Sebastian, Wilfried E.E. Eberhardt,Petra Hoffknecht, Martin Metzenmacher, Thomas Wehler, Konr… , 2021. - 11 S.
  In: Lung cancer, ISSN 1872-8332. 154(2021) vom: Apr., Seite 51-61
  DOI: 10.1016/j.lungcan.2021.02.005
• Volckmar, Anna-Lena: Targeting rare and non-canonical driver variants in NSCLC : an uncharted clinical field / Anna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, Michael Allgäuer, Olaf Neumann, Jan Budc… , 19 February 2021. - 11 S.
  In: Lung cancer, ISSN 1872-8332. 154(2021) vom: Apr., Seite 131-141
  DOI: 10.1016/j.lungcan.2021.02.022
• Bozorgmehr, Farastuk: De Novo versus secondary metastatic EGFR-mutated non-small-cell lung cancer / Farastuk Bozorgmehr, Daniel Kazdal, Inn Chung, Martina Kirchner, Nikolaus Magios, Mark Kriegsmann, M… , 09 April 2021. - 9 S.
  In: Frontiers in oncology, ISSN 2234-943X. 11(2021), Artikel-ID 640048, Seite 1-9
  DOI: 10.3389/fonc.2021.640048
• Baum, Philip: Validation of the T descriptor (TNM-8) in T3N0 non-small-cell lung cancer patients : a bicentric cohort analysis with arguments for redefinition / Philip Baum, Samantha Taber, Stella Erdmann, Thomas Muley, Mark Kriegsmann, Petros Christopoulos, Mi… , 10 April 2021. - 10 S.
  In: Cancers, ISSN 2072-6694. 13(2021), 8, Artikel-ID 1812, Seite 1-10
  DOI: 10.3390/cancers13081812
• Metzenmacher, Martin: A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer / Martin Metzenmacher, Hans-Georg Kopp, Frank Griesinger, Niels Reinmuth, Martin Sebastian, Monika Ser… , March 9, 2021. - 16 S.
  In: Therapeutic advances in medical oncology, ISSN 1758-8359. 13(2021) vom: Jan., Artikel-ID 1758835921996506, Seite 1-16
  DOI: 10.1177/1758835921996506
• El Sayed, Mei: Feasibility and challenges for sequential treatments in ALK-rearranged non-small-cell lung cancer / Mei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, Anna-Lena Volckmar, Holger Sültmann, Jürgen R. Fisc… , 20 April 2021. - 8 S.
  In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: Apr., Artikel-ID 670483, Seite 1-8
  DOI: 10.3389/fonc.2021.670483
• Eichhorn, Florian: Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer : first clinical experience / Florian Eichhorn, Laura V. Klotz, Mark Kriegsmann, Helge Bischoff, Marc A. Schneider, Thomas Muley, … , 21 January 2021. - 8 S.
  In: Lung cancer, ISSN 1872-8332. 153(2021), Seite 150-157
  DOI: 10.1016/j.lungcan.2021.01.018
• Goldmann, Torsten: DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer / Torsten Goldmann, Bernhard Schmitt, Julia Müller, Maren Kröger, Swetlana Scheufele, Sebastian Marwit… , 17 February 2021. - 11 S.
  In: Clinical epigenetics, ISSN 1868-7083. 13(2021), Artikel-ID 38, Seite 1-11
  DOI: 10.1186/s13148-021-01024-6
• Langer, Corey J.: Nab-paclitaxel/carboplatin in vulnerable populations with advanced non-small cell lung cancer : pooled analysis / Corey J. Langer, Ajeet Gajra, Cesare Gridelli, Kartik Konduri, Daniel Morgensztern, David Spigel, De… , 26 January 2021. - 10 S.
  In: Frontiers in oncology, ISSN 2234-943X. 10(2021), Artikel-ID 485587, Seite 1-10
  DOI: 10.3389/fonc.2020.485587
• Bossert, Jasmin: Lung cancer patients’ comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study / Jasmin Bossert, Marion Ludwig, Pamela Wronski, Jan Koetsenruijter, Katja Krug, Matthias Villalobos, … , 28 January 2021. - 6 S.
  In: npj Primary care respiratory medicine, ISSN 2055-1010. 31(2021), Artikel-ID 2, Seite 1-6
  DOI: 10.1038/s41533-020-00214-8
• Brunn, David: Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican / David Brunn, Kati Turkowski, Stefan Günther, Andreas Weigert, Thomas Muley, Mark Kriegsmann, Hauke W… , 8 January 2021
  In: Cancers, ISSN 2072-6694. 13(2021,2) Artikel-Nummer 208, 19 Seiten
  DOI: 10.3390/cancers13020208
• Budczies, Jan: A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma / Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Krie… , 11 January 2021. - 14 S. : Illustrationen, Diagramme
  In: OncoImmunology, ISSN 2162-402X. 10(2021), Artikel-ID 1860586, Seite 1-14
  DOI: 10.1080/2162402x.2020.1860586
• Catarata, Maria Joana: Germline genetic variants of the renin-angiotensin system, hypoxia and angiogenesis in non-small cell lung cancer progression : discovery and validation studies / Maria Joana Catarata, Rui Medeiros, Maria José Oliveira, Alice Pêgo, João Gonçalo Frade, Maria Fátim… , 18 December 2020. - 16 S.
  In: Cancers, ISSN 2072-6694. 12(2020), 12, Artikel-ID 3834, Seite 1-16
  DOI: 10.3390/cancers12123834
• Dietz, Steffen: Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA / Steffen Dietz, Petros Christopoulos, Zhao Yuan, Arlou Kristina Angeles, Lisa Gu, Anna-Lena Volckmar,… , 9 November 2020. - 10 S.
  In: EBioMedicine, ISSN 2352-3964. 62(2020), 12, Artikel-ID 103103, Seite 1-10
  DOI: 10.1016/j.ebiom.2020.103103
• Griesinger, Frank: Biomarker testing in non-small cell lung cancer in routine care : analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315) / Frank Griesinger, Wilfried Eberhardt, Arnd Nusch, Marcel Reiser, Mark-Oliver Zahn, Christoph Maintz,… , 2021. - 11 S.
  In: Lung cancer, ISSN 1872-8332. 152(2021) vom: Feb., Seite 174-184
  DOI: 10.1016/j.lungcan.2020.10.012
• Spigel, David: Nanoparticle albumin-bound paclitaxel plus carboplatin induction followed by nanoparticle albumin-bound paclitaxel maintenance in squamous non-small-cell lung cancer (ABOUND.sqm) : a phase III randomized clinical trial / David R. Spigel, Robert M. Jotte, Santiago Ponce Aix, Laurent Gressot, Daniel Morgensztern, Michael … , 2021. - 14 S.
  In: Clinical lung cancer, ISSN 1938-0690. 22(2021), 1, Seite 6-15.e4
  DOI: 10.1016/j.cllc.2020.09.007
• Wolf, Jürgen: Capmatinib in MET Exon 14-mutated or MET-amplified non-small-cell lung cancer / J. Wolf, T. Seto, J.-Y. Han, N. Reguart, E.B. Garon, H.J.M. Groen, D.S.W. Tan, T. Hida, M. de Jonge,… , September 3, 2020. - 14 S.
  In: The New England journal of medicine, ISSN 1533-4406. 383(2020), 10, Seite 944-957
  DOI: 10.1056/NEJMoa2002787
• Christopoulos, Petros: Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing / P. Christopoulos, M. Kirchner, J. Roeper, F. Saalfeld, M. Janning, F. Bozorgmehr, N. Magios, D. Kazd… , 22 August 2020. - 8 S.
  In: Lung cancer, ISSN 1872-8332. 148(2020), Seite 105-112
  DOI: 10.1016/j.lungcan.2020.08.007
• Wessels, Sabine: Comprehensive serial biobanking in advanced NSCLC : feasibility, challenges and perspectives / Sabine Wessels, Thomas Muley, Petros Christopoulos, Michael Meister, Ingrid Heinzmann-Groth, Arne Wa… , August 2020. - 15 S.
  In: Translational Lung Cancer Research, ISSN 2226-4477. 9(2020), 4, Seite 1000-1014
  DOI: 10.21037/tlcr-20-137
• Eichkorn, Tanja: Consolidation immunotherapy after platinum-based chemoradiotherapy in patients with unresectable stage III non-small cell lung cancer : cross-sectional study of eligibility and administration rates / Tanja Eichkorn, Farastuk Bozorgmehr, Sebastian Regnery, Lisa A. Dinges, Andreas Kudak, Nina Bougatf,… , 01 December 2020. - 9 S.
  In: Frontiers in oncology, ISSN 2234-943X. 10(2020) Artikel-Nummer 586449, 9 Seiten
  DOI: 10.3389/fonc.2020.586449
• Kriegsmann, Mark: Mass spectrometry imaging for reliable and fast classification of non-small cell lung cancer subtypes / Mark Kriegsmann, Christiane Zgorzelski, Rita Casadonte, Kristina Schwamborn, Thomas Muley, Hauke Win… , 21 September 2020. - 14 S.
  In: Cancers, ISSN 2072-6694. 12(2020,9) Artikel-Nummer 2704, 14 Seiten
  DOI: 10.3390/cancers12092704
• Regnery, Sebastian: Progression of pulmonary function and correlation with survival following stereotactic body radiotherapy of central and ultracentral lung tumors / Sebastian Regnery, Tanja Eichkorn, Fabian Weykamp, Thomas Held, Lisa-Antonia Dinges, Fabian Schunn, … , 5 October 2020. - 14 S.
  In: Cancers, ISSN 2072-6694. 12(2020,10) Artikel-Nummer 2862, 14 Seiten
  DOI: 10.3390/cancers12102862
• Thomas, Michael: Editorial / Michael Thomas, Wolfgang Schütte, 21 September 2020. - 1 S.
  In: Oncology research and treatment, ISSN 2296-5262. 43(2020), Suppl. 3, Seite 5
  DOI: 10.1159/000510546
• Bozorgmehr, Farastuk: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy : study protocol of the TRADE-hypo trial / Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brück… , 26 August 2020. - 10 S.
  In: BMC cancer, ISSN 1471-2407. 20(2020) Artikel-Nummer 806, 9 Seiten
  DOI: 10.1186/s12885-020-07264-8
• Kim-Wanner, Soo-Zin: Genome-wide DNA methylation profiling in early stage I lung adenocarcinoma reveals predictive aberrant methylation in the promoter region of the long noncoding RNA PLUT : an exploratory study / Soo-Zin Kim-Wanner, MD, Yassen Assenov, PhD, Mridul B. Nair, PhD, Dieter Weichenhan, PhD, Axel Benne… , 7 April 2020. - 13 S.
  In: Journal of thoracic oncology, ISSN 1556-1380. 15(2020), 8, Seite 1338-1350
  DOI: 10.1016/j.jtho.2020.03.023
• Turkowski, Kati: Fibroblast growth factor-14 acts as tumor suppressor in lung adenocarcinomas / Kati Turkowski, Frederik Herzberg, Stefan Günther, David Brunn, Andreas Weigert, Michael Meister, Th… , 22 July 2020. - 19 S.
  In: Cells, ISSN 2073-4409. 9(2020,8) Artikel-Nummer 1755, 19 Seiten
  DOI: 10.3390/cells9081755
• Bossert, Jasmin: What patients with lung cancer with comorbidity tell us about interprofessional collaborative care across healthcare sectors : qualitative interview study / Jasmin Bossert, Johanna Forstner, Matthias Villalobos, Anja Siegle, Corinna Jung, Nicole Deis, Micha… , 4 August 2020. - 8 S.
  In: BMJ open, ISSN 2044-6055. 10(2020,8) Artikel-Nummer e036495, 8 Seiten
  DOI: 10.1136/bmjopen-2019-036495
• Kriegsmann, Mark: Deep learning for the classification of small-cell and non-small-cell lung cancer / Mark Kriegsmann, Christian Haag, Cleo-Aron Weis, Georg Steinbuss, Arne Warth, Christiane Zgorzelski,… , 17 June 2020. - 16 S.
  In: Cancers, ISSN 2072-6694. 12(2020,6) Artikel-Nummer 1604, 16 Seiten
  DOI: 10.3390/cancers12061604
• Janke, Florian: Novel liquid biomarker panels for a very early response capturing of NSCLC therapies in advanced stages / Florian Janke, Farastuk Bozorgmehr, Sabine Wrenger, Steffen Dietz, Claus P. Heussel, Gudula Heussel,… , 12 April 2020. - 18 S.
  In: Cancers, ISSN 2072-6694. 12(2020,4) Artikel-Nummer 954, 18 Seiten
  DOI: 10.3390/cancers12040954
• Rheinheimer, Stephan: Oligoprogressive non-small-cell lung cancer under treatment with PD-(L)1 inhibitors / Stephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, Lena Gaissmaier, Farastuk Bozorgmehr, Hauke… , 23 April 2020. - 13 S.
  In: Cancers, ISSN 2072-6694. 12(2020), 4, Artikel-ID 1046, Seite 1-13
  DOI: 10.3390/cancers12041046
• Kuon, Jonas: Durvalumab in frail and elderly patients with stage four non-small cell lung cancer : study protocol of the randomized phase II DURATION trial / Jonas Kuon, Adriane Hommertgen, Johannes Krisam, Felix Lasitschka, Albrecht Stenzinger, Miriam Blasi… , 22 April 2020. - 12 S.
  In: Trials, ISSN 1468-6694. 21(2020) Artikel-Nummer 352, 12 Seiten
  DOI: 10.1186/s13063-020-04280-8
• Budczies, Jan: Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement / Jan Budczies, Daniel Kazdal, Michael Allgäuer, Petros Christopoulos, Eugen Rempel, Nicole Pfarr, Wil… , 1 February 2020. - 6 S.
  In: Lung cancer, ISSN 1872-8332. 142(2020), Seite 114-119
  DOI: 10.1016/j.lungcan.2020.01.019
• Eiff, Damian von: Paclitaxel for treatment of advanced small cell lung cancer (SCLC) : a retrospective study of 185 patients / Damian von Eiff, Farastuk Bozorgmehr, Inn Chung, Denise Bernhardt, Stefan Rieken, Stephan Liersch, T… , [2020]. - 12 S.
  In: Journal of thoracic disease, ISSN 2077-6624. 12(2020), 3, Seite 782-793
  DOI: 10.21037/jtd.2019.12.74
• Bossert, Jasmin: Implementation of the milestones communication approach for patients with limited prognosis : evaluation of intervention fidelity / Jasmin Bossert, Michel Wensing, Michael Thomas, Matthias Villalobos, Corinna Jung, Anja Siegle, Laur… , 18 February 2020. - 10 S.
  In: BMC palliative care, ISSN 1472-684X. 19(2020), Artikel-ID 21, Seite 1-10
  DOI: 10.1186/s12904-020-0527-1
• Marwitz, Sebastian: The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC / Sebastian Marwitz, Kati Turkowski, Dörte Nitschkowski, Andreas Weigert, Julius Brandenburg, Norbert … , 21 January 2020. - 13 S.
  In: Frontiers in oncology, ISSN 2234-943X. 9(2020) Artikel-Nummer 1550, 13 Seiten
  DOI: 10.3389/fonc.2019.01550
• Garon, Edward B.: Exploratory analysis of front-line therapies in REVEL : a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy / Edward B. Garon, Giorgio Vittorio Scagliotti, Oliver Gautschi, Martin Reck, Michael Thomas, Lara Igl… , 2020
  In: ESMO open, ISSN 2059-7029. 5(2020,1) Artikel-Nummer e000567, 11 Seiten
  DOI: 10.1136/esmoopen-2019-000567
• Dietz, Steffen: Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer / Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna-Lena Volckmar, Volker Endris, Zhao Yuan, Simon J.… , November 21, 2019. - 10 S.
  In: Cold Spring Harbor molecular case studies, ISSN 2373-2873. 5(2019,6) Artikel-Nummer a004630, 10 Seiten
  DOI: 10.1101/mcs.a004630
• Christopoulos, Petros: Defining molecular risk in ALK + NSCLC / Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas… , May 03, 2019. - 11 S.
  In: OncoTarget, ISSN 1949-2553. 10(2019), 33, Seite 3093-3103
  DOI: 10.18632/oncotarget.26886
• Bozorgmehr, Farastuk: Fostering efficacy of anti-PD-1-treatment : Nivolumab plus radiotherapy in advanced non-small cell lung cancer : study protocol of the FORCE trial / Farastuk Bozorgmehr, Adriane Hommertgen, Johannes Krisam, Felix Lasitschka, Jonas Kuon, Martin Maenz… , 08 November 2019. - 11 S.
  In: BMC cancer, ISSN 1471-2407. 19(2019) Artikel-Nummer 1074, 11 Seiten
  DOI: 10.1186/s12885-019-6205-0
• Kuon, Jonas: Symptoms and needs of patients with advanced lung cancer : early prevalence assessment / Jonas Kuon, Jeannette Vogt, Anja Mehnert, Bernd Alt-Epping, Birgitt van Oorschot, Jochen Sistermanns… , October 21, 2019. - 10 S.
  In: Oncology research and treatment, ISSN 2296-5262. 42(2019), 12, Seite 650-659
  DOI: 10.1159/000502751
• Eichhorn, Florian: Neoadjuvant anti-programmed death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC) : the NEOMUN trial / Florian Eichhorn, Laura V. Klotz, Helge Bischoff, Michael Thomas, Felix Lasitschka, Hauke Winter, Ha… , 02 May 2019. - 10 S.
  In: BMC cancer, ISSN 1471-2407. 19(2019) Artikel-Nummer 413, 8 Seiten
  DOI: 10.1186/s12885-019-5624-2
• Thomas, Michael: Totality of evidence in the development of ABP 215, an approved bevacizumab biosimilar / Michael Thomas, Nick Thatcher, Jerome Goldschmidt, Yuichiro Ohe, Helen J. McBride, Vladimir Hanes, 26 September 2019. - 15 S.
  In: Immunotherapy, ISSN 1750-7448. 11(2019), 15, Seite 1337-1351
  DOI: 10.2217/imt-2019-0125
• Villalobos Bollen, Matthias Americo: Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab / Matthias Villalobos, Piotr Czapiewski, Niels Reinmuth, Jürgen R. Fischer, Stefan Andreas, Cornelius … , February 21, 2019. - 10 S.
  In: Oncology letters, ISSN 1792-1082. 17(2019), 6, Seite 4891-4900
  DOI: 10.3892/ol.2019.10153
• Thatcher, Nicholas: Efficacy and safety of the biosimilar ABP 215 compared with Bevacizumab in patients with advanced nonsquamous non-small cell lung cancer (MAPLE) : a randomized, double-blind, phase III study / Nicholas Thatcher, Jerome H. Goldschmidt, Michael Thomas, Michael Schenker, Zhiying Pan, Luis Paz-Ar… , January 7, 2019. - 8 S.
  In: Clinical cancer research, ISSN 1557-3265. 25(2019), 7, Seite 2088-2095
  DOI: 10.1158/1078-0432.CCR-18-2702
• Kazdal, Daniel: Spatial and temporal heterogeneity of panel-based tumor mutational burden in pulmonary adenocarcinoma : separating biology from technical artifacts / Daniel Kazdal, Volker Endris, Michael Allgäuer, Mark Kriegsmann, Jonas Leichsenring, Anna-Lena Volck… , 23 July 2019. - 13 S.
  In: Journal of thoracic oncology, ISSN 1556-1380. 14(2019), 11, Seite 1935-1947
  DOI: 10.1016/j.jtho.2019.07.006
• Budczies, Jan: Optimizing panel-based tumor mutational burden (TMB) measurement / J. Budczies, M. Allgäuer, K. Litchfield, E. Rempel, P. Christopoulos, D. Kazdal, V. Endris, M. Thoma… , 3 July 2019. - 11 S.
  In: Annals of oncology, ISSN 1569-8041. 30(2019), 9, Seite 1496-1506
  DOI: 10.1093/annonc/mdz205
• Leichsenring, Jonas: Variant classification in precision oncology / Jonas Leichsenring, Peter Horak, Simon Kreutzfeldt, Christoph Heining, Petros Christopoulos, Anna-Le… , 22 April 2019. - 15 S.
  In: International journal of cancer, ISSN 1097-0215. 145(2019), 11, Seite 2996-3010
  DOI: 10.1002/ijc.32358
• Sebastian, Martin: A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer / Martin Sebastian, Andreas Schröder, Birgit Scheel, Henoch S. Hong, Anke Muth, Lotta von Boehmer, Alf… , 15 February 2019. - 14 S.
  In: Cancer immunology immunotherapy, ISSN 1432-0851. 68(2019), 5, Seite 799-812
  DOI: 10.1007/s00262-019-02315-x
• Eichhorn, Florian: Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC) : the NEOMUN trial / Florian Eichhorn, Laura V. Klotz, Helge Bischoff, Michael Thomas, Felix Lasitschka, Hauke Winter, Ha… . -
  London: BioMed Central, 2019. - 1 Online-Ressource
• Christopoulos, Petros: Detection of TP53 mutations in tissue or liquid rebiopsies at progression identifies ALK+ lung cancer patients with poor survival / Petros Christopoulos, Steffen Dietz, Martina Kirchner, Anna-Lena Volckmar, Volker Endris, Olaf Neuma… , 21 January 2019. - 9 S.
  In: Cancers, ISSN 2072-6694. 11(2019,1) Artikel-Nummer 124, 9 Seiten
  DOI: 10.3390/cancers11010124
• Christopoulos, Petros: Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma / P. Christopoulos, M. Kirchner, F. Bozorgmehr, V. Endris, M. Elsayed, J. Budczies, J. Ristau, R. Penz… , [1 January 2019]. - 10 S.
  In: International journal of cancer, ISSN 1097-0215. 144(2019), 1, Seite 190-199
  DOI: 10.1002/ijc.31893
• Buchhalter, Ivo: Size matters : Dissecting key parameters for panel-based tumor mutational burden analysis / Ivo Buchhalter, Eugen Rempel, Volker Endris, Michael Allgäuer, Olaf Neumann, Anna-Lena Volckmar, Mar… , 2019. - 11 S.
  In: International journal of cancer, ISSN 1097-0215. 144(2019), 4, Seite 848-858
  DOI: 10.1002/ijc.31878
• Volckmar, Anna-Lena: Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics : analysis of the first 3000 Heidelberg cases / Anna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, Petros Christopoulos, Olaf Neumann, Jan Bu… , 17 January 2019. - 13 S.
  In: International journal of cancer, ISSN 1097-0215. 145(2019), 3, Seite 649-661
  DOI: 10.1002/ijc.32133
• Allgäuer, Michael: Implementing tumor mutational burden (TMB) analysis in routine diagnostics : a primer for molecular pathologists and clinicians / Michael Allgäuer, Jan Budczies, Petros Christopoulos, Volker Endris, Amelie Lier, Eugen Rempel, Anna… , Aug 15, 2018. - 13 S.
  In: Translational Lung Cancer Research, ISSN 2226-4477. 7(2018), 6, Seite 703-715
  DOI: 10.21037/tlcr.2018.08.14
• Viehrig, Marén: SOP : Schmerztherapie bei Palliativpatienten = / Marén Viehrig, Barbara Schlisio, Michael Thomas, Jan Gärtner, Carolin Wolf, Jörg Hense, 18 October 2018. - 11 S.
  In: Der Onkologe, ISSN 1433-0415. 24(2018), 1, Seite 7-17
  DOI: 10.1007/s00761-018-0416-x
• Montag, Thomas: SOP - Behandlung und Betreuung in der Sterbephase : = / Thomas Montag, Barbara Starbatty, Michael Thomas, Christiane Gog, Christoph Ostgathe, Steffen Simon, 18 October 2018. - 4 S.
  In: Der Onkologe, ISSN 1433-0415. 24(2018), 1, Seite S82-S85
  DOI: 10.1007/s00761-018-0410-3
• Steins, Martin: Erlotinib / Martin Steins, Michael Thomas, Michael Geißler, 02 August 2018. - 17 S.
  In: Small molecules in oncology. (2018), Seite 1-17
  DOI: 10.1007/978-3-319-91442-8_1
• Schneider, Marc: Glycodelin as a serum and tissue biomarker for metastatic and advanced NSCLC / Marc A. Schneider, Thomas Muley, Rebecca Weber, Sabine Wessels, Michael Thomas, Felix J. F. Herth, N… , 4 December 2018. - 12 S.
  In: Cancers, ISSN 2072-6694. 10(2018,12), Artikel-Nummer 486, 12 Seiten
  DOI: 10.3390/cancers10120486
• Eschbach, Corinna: SOP : Inappetenz und Kachexie = / C. Eschbach, P. Stachura, M. Villalobos, C. Wolf, M. Thomas, 18 October 2018. - 6 S.
  In: Der Onkologe, ISSN 1433-0415. 24(2018), S1, Seite 35-40
  DOI: 10.1007/s00761-018-0415-y
• Melnik, Svitlana: Cancer cell specific inhibition of Wnt/β-catenin signaling by forced intracellular acidification / Svitlana Melnik, Dmytro Dvornikov, Karin Müller-Decker, Sofia Depner, Peter Stannek, Michael Meister… , July 3, 2018. - 17 S.
  In: Cell discovery, ISSN 2056-5968. 4(2018), Artikel-ID 37, Seite 1-17
  DOI: 10.1038/s41421-018-0033-2
• Villalobos Bollen, Matthias Americo: ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer / Matthias Villalobos, Piotr Czapiewski, Niels Reinmuth, Jürgen R. Fischer, Stefan Andreas, Cornelius … , 15 June 2018. - 8 S.
  In: Medical oncology, ISSN 1559-131X. Band 35.2018, Artikel-Nummer 106, 8 Seiten
  DOI: 10.1007/s12032-018-1169-5
• Jentschke, Elisabeth: SOP - Akuter Verwirrtheitszustand / Elisabeth Jentschke, Michael Thomas, Anna Babiak, Jan Lewerenz, Karin Oechsle, Birgitt van Oorschot … , 18 October 2018. - 5 S.
  In: Der Onkologe, ISSN 1433-0415. 24(2018), S1, Seite 55-59
  DOI: 10.1007/s00761-018-0407-y
• Schwartz, Jacqueline: SOP - Depression und Angst in der Palliativmedizin / Jacqueline Schwartz, Martin Neukirchen, Marie-Christine De Vilder, Beate Hornemann, Carolin Wolf, Ja… , 18 October 2018. - 7 S.
  In: Der Onkologe, ISSN 1433-0415. 24(2018), S1, Seite 48-54
  DOI: 10.1007/s00761-018-0418-8
• Titz, Christina: Exercise behavior and physical fitness in patients with advanced lung cancer / Christina Titz, Simone Hummler, Martina E. Schmidt, Michael Thomas, Martin Steins, Joachim Wiskemann, 26 February 2018. - 12 S.
  In: Supportive care in cancer, ISSN 1433-7339. 26(2018), 8, Seite 2725-2736
  DOI: 10.1007/s00520-018-4105-5
• Thuss-Patience, Peter: SOP - Übelkeit und Erbrechen bei Palliativpatienten / Peter Thuss-Patience, Janett Markwordt, Regine Mayer-Steinacker, Thomas Ettrich, Carolin Wolf, Peter… , 18 October 2018. - 6 S.
  In: Der Onkologe, ISSN 1433-0415. 24(2018), S1, Seite 29-34
  DOI: 10.1007/s00761-018-0417-9
• Thomas, Michael: Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer : results from the exploratory, controlled, randomized, international phase II IMPULSE study / M. Thomas, S. Ponce-Aix, A. Navarro, J. Riera-Knorrenschild, M. Schmidt, E. Wiegert, K. Kapp, B. Wit… , 20 August 2018. - 9 S.
  In: Annals of oncology, ISSN 1569-8041. 29(2018), 6, Seite 1409-1416
  DOI: 10.1093/annonc/mdy326
• Bernhardt, Denise: Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy / Denise Bernhardt, Sophie Aufderstrasse, Laila König, Sebastian Adeberg, Farastuk Bozorgmehr, Petros … , 30 November 2018. - 7 S.
  In: Cancer management and research, ISSN 1179-1322. 10(2018), Seite 6563-6569
  DOI: 10.2147/CMAR.S180990
• Dvornikov, Dmytro: Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response / D. Dvornikov, M.A. Schneider, S. Ohse, M. Szczygieł, I. Titkova, M. Rosenblatt, T. Muley, A. Warth, … , 22 June 2018. - 13 S.
  In: Scientific reports, ISSN 2045-2322. 8(2018) Artikel-Nummer 9517, 13 Seiten
  DOI: 10.1038/s41598-018-27912-1
• Endris, Volker: Measurement of tumor mutational burden (TMB) in routine molecular diagnostics : in silico and real-life analysis of three larger gene panels / Volker Endris, Ivo Buchhalter, Michael Allgäuer, Eugen Rempel, Amelie Lier, Anna-Lena Volckmar, Mart… , 2019. - 10 S.
  In: International journal of cancer, ISSN 1097-0215. 144(2019), 9, Seite 2303-2312
  DOI: 10.1002/ijc.32002
• Christopoulos, Petros: Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance / Petros Christopoulos, Marc A. Schneider, Farastuk Bozorgmehr, Jonas Kuon, Walburga Engel-Riedel, Jen… , [May 2018]. - 8 S. : Illustrationen
  In: Lung cancer, ISSN 1872-8332. 119(2018), Seite 48-55
  DOI: 10.1016/j.lungcan.2018.03.002
• Christopoulos, Petros: EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer / Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr, Mei Elsayed, Martina Kirchner, Jonas Rista… , [15 June 2018]. - 10 S.
  In: International journal of cancer, ISSN 1097-0215. 142(2018), 12, Seite 2589-2598
  DOI: 10.1002/ijc.31275
• Christopoulos, Petros: Deficient CD247 expression is a typical histopathological characteristic of thymomas with cortical features / Petros Christopoulos, Inn Chung, Farastuk Bozorgmehr, Thomas Muley, Michael Meister, Sonja Kobinger,… , [December 2018]. - 4 S. : Illustrationen
  In: Histopathology, ISSN 1365-2559. 73(2018), 6, Seite 1040-1043
  DOI: 10.1111/his.13724
• Berendt, Julia: Integration von Palliativmedizin in onkologische Spitzenzentren Deutschlands : ambulante Sprechstunden und Rotationsprogramme der spezialisierten Palliativmedizin = / Julia Berendt, Michael Thomas, Martin Neukirchen, Jacqueline Schwartz, Jörg Hense, Mitra Tewes, 2018. - 7 S.
  In: Deutsche medizinische Wochenschrift, ISSN 1439-4413. 143(2018), 17, Seite e139-e145
  DOI: 10.1055/a-0626-9934
• Weber, Rebecca: Pathways regulating the expression of the immunomodulatory protein glycodelin in non‑small cell lung cancer / Rebecca Weber, Michael Meister, Thomas Muley, Michael Thomas, Holger Sültmann, Arne Warth, Hauke Win… , 2019. - 12 S.
  In: International journal of oncology, ISSN 1791-2423. 54(2019), 2, Seite 515-526
  DOI: 10.3892/ijo.2018.4654
• Siegle, Anja: The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months : protocol for a mixed-methods study including a randomized controlled trial / Anja Siegle; Matthias Villalobos; Jasmin Bossert; Katja Krug; Laura Hagelskamp; Johannes Krisam; Vio… . -
  London: BioMed Central, 2018. - 1 Online-Ressource (13 Seiten)
  DOI: 10.1186/s13063-018-2814-1
• Bernhardt, Denise: Whole brain radiation therapy alone versus radiosurgery for patients with 1–10 brain metastases from small cell lung cancer (ENCEPHALON Trial) : study protocol for a randomized controlled trial / Denise Bernhardt; Adriane Hommertgen; Daniela Schmitt; Rami El Shafie; Angela Paul; Laila König; Joh… . -
  London: BioMed Central, 2018. - 1 Online-Ressource
  DOI: 10.1186/s13063-018-2745-x
• Bernhardt, Denise: Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial) : study protocol for a randomized controlled trial / Denise Bernhardt, Adriane Hommertgen, Daniela Schmitt, Rami El Shafie, Angela Paul, Laila König, Joh… , 16 July 2018. - 8 S.
  In: Trials, ISSN 1468-6694. 19(2018), Artikel-ID 388, Seite 1-8
  DOI: 10.1186/s13063-018-2745-x
• Bernhardt, Denise: Generation of a new disease-specific prognostic score for patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy (BMS-score) and validation of two other indices / Denise Bernhardt, Laila König, Sophie Aufderstrasse, Johannes Krisam, Juliane Hoerner-Rieber, Sebast… , 2018. - 6 S.
  In: Clinical lung cancer, ISSN 1938-0690. 19(2018), 4, Seite 340-345
  DOI: 10.1016/j.cllc.2017.12.004
• Bernhardt, Denise: Outcome and prognostic factors in single brain metastases from small-cell lung cancer / Denise Bernhardt, Sebastian Adeberg, Farastuk Bozorgmehr, Nils Opfermann, Juliane Hörner-Rieber, Lai… , 2018. - 9 S.
  In: Strahlentherapie und Onkologie, ISSN 1439-099X. 194(2018), 2, Seite 98-106
  DOI: 10.1007/s00066-017-1228-4
• Schütte, Wolfgang: Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany : an observational study / Wolfgang Schuette, Peter Schirmacher, Wilfried E.E. Eberhardt, Manfred Dietel, Ute Zirrgiebel, Lars … . -
  London: BioMed Central, 05 February 2018. - 1 Online-Ressource (10 Seiten)
  DOI: 10.1186/s12885-018-4032-3
• Wehler, Thomas Christian: A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non‐small cell lung cancer / Thomas Wehler, Michael Thomas, Christian Schumann, Joaquim Bosch-Barrera, Nuria Viñolas Segarra, Nic… , June 2017. - 5 S.
  In: Lung cancer, ISSN 1872-8332. 108(2017), Seite 212-216
  DOI: 10.1016/j.lungcan.2017.03.001
• Eschbach, Corinna: SOP : Inappetenz und Kachexie / C. Eschbach, P. Stachura, M. Villalobos, C. Wolf, M. Thomas, August 2017. - 6 S.
  In: Der Onkologe, ISSN 1433-0415. 23(2017), 8, Seite 651-656
  DOI: 10.1007/s00761-017-0250-6
• Haun, Markus W.: Early palliative care for adults with advanced cancer / Markus W. Haun, Stephanie Estel, Gerta Rücker, Hans-Christoph Friederich, Matthias Villalobos, Micha… , 12 June 2017. - 107 S.
  In: The Cochrane database of systematic reviews, ISSN 1469-493X. (2017), 6, Artikel-ID CD011129, Seite 1-105
  DOI: 10.1002/14651858.CD011129.pub2
• Viehrig, Marén: SOP - Schmerztherapie bei Palliativpatienten / Marén Viehrig, Barbara Schlisio, Michael Thomas, Jan Gärtner, Carolin Wolf, Jörg Hense, 16. Juni 2017. - 11 S.
  In: Der Onkologe, ISSN 1433-0415. 23(2017), 7, Seite 555-565
  DOI: 10.1007/s00761-017-0251-5
• Villalobos Bollen, Matthias Americo: A longitudinal communication approach in advanced lung cancer : a qualitative study of patients’, relatives’ and staff's perspectives / M. Villalobos MD (senior physician), K. Coulibaly MD (doctoral student), K. Krug Dr. Dipl-Psych (res… , 2018. - 8 S.
  In: European journal of cancer care, ISSN 1365-2354. 27(2018), 2, Artikel-ID e12794, Seite 1-8
  DOI: 10.1111/ecc.12794
• Castro, Javier de: Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC) : PIvOTAL study / J. de Castro, P. Tagliaferri, V.C.C. de Lima, S. Ng, M. Thomas, A. Arunachalam, X. Cao, S. Kothari, …
  In: European journal of cancer care, ISSN 1365-2354. 26(2017,2) Artikel-Nummer e12734, 15 Seiten
  DOI: 10.1111/ecc.12734
• Jentschke, Elisabeth: SOP - Akuter Verwirrtheitszustand / Elisabeth Jentschke, Michael Thomas, Anna Babiak, Jan Lewerenz, Karin Oechsle, Birgitt van Oorschot,… . - 5 S.
  In: Der Onkologe, ISSN 1433-0415. 23(2017), 3, S. 213-217
  DOI: 10.1007/s00761-017-0195-9
• Christopoulos, Petros: A mighty oak in the rapidly expanding field of checkpoint inhibition for NSCLC / Petros Christopoulos, Michael Thomas, Feb 09, 2017. - 3 S.
  In: Journal of thoracic disease, ISSN 2077-6624. 9(2017), 3, Seite E292-E294
  DOI: 10.21037/jtd.2017.02.86
• Christopoulos, Petros: Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma : a multicenter phase II trial / P. Christopoulos, W. Engel-Riedel, C. Grohé, C. Kropf-Sanchen, J. von Pawel, S. Gütz, J. Kollmeier, … . - 5 S.
  In: Annals of oncology, ISSN 1569-8041. 28(2017), 8, S. 1898-1902
  DOI: 10.1093/annonc/mdx268
• Schneider, Marc: AURKA, DLGAP5, TPX2, KIF11 and CKAP5 : five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients / Marc A. Schneider, Petros Christopoulos, Thomas Muley, Arne Warth, Ursula Klingmueller, Michael Thom… , 2017. - 8 S.
  In: International journal of oncology, ISSN 1791-2423. 50(2017), 2, Seite 365-372
  DOI: 10.3892/ijo.2017.3834
• Thuss-Patience, Peter: SOP - Übelkeit und Erbrechen bei Palliativpatienten / Peter Thuss-Patience, Janett Markwordt, Regine Mayer-Steinacker, Thomas Ettrich, Carolin Wolf, Peter… , 2017. - 6 S.
  In: Der Onkologe, ISSN 1433-0415. 23(2017), 9, Seite 750-755
  DOI: 10.1007/s00761-017-0259-x
• Schmidt, Lars Henning: CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer / Lars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, Christoph Schliemann, Saliha Harrach, Thom… , 22 September 2017. - 7 S.
  In: Lung cancer, ISSN 1872-8332. 113(2017), Seite 121-127
  DOI: 10.1016/j.lungcan.2017.09.013
• Bernhardt, Denise: Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy / Denise Bernhardt, Sebastian Adeberg, Farastuk Bozorgmehr, Nils Opfermann, Juliane Hoerner-Rieber, La… , 30 May 2017. - 8 S.
  In: Journal of neuro-oncology, ISSN 1573-7373. 134(2017), 1, Seite 205-212
  DOI: 10.1007/s11060-017-2510-0
• Schwartz, Jacqueline: SOP - Depression und Angst in der Palliativmedizin / Jacqueline Schwartz, Martin Neukirchen, Marie-Christine De Vilder, Beate Hornemann, Carolin Wolf, Ja… . - 8 S.
  In: Der Onkologe, ISSN 1433-0415. 23(2017), 9, S. 756-763
  DOI: 10.1007/s00761-017-0260-4
• Thomas, Michael: A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer / M. Thomas, P. Sadjadian, J. Kollmeier, J. Lowe, P. Mattson, J.R. Trout, M. Gargano, M.L. Patchen, R.… . - 14 S.
  In: Investigational new drugs, ISSN 1573-0646. 35(2017), 3, S. 345-358
  DOI: 10.1007/s10637-017-0450-3
• Montag, Thomas: SOP - Behandlung und Betreuung in der Sterbephase / Thomas Montag, Barbara Starbatty, Michael Thomas, Christiane Gog, Christoph Ostgathe, Steffen Simon. - 4 S.
  In: Der Onkologe, ISSN 1433-0415. 23(2017), 5, S. 385-388
  DOI: 10.1007/s00761-017-0213-y
• Reck, Martin: Outcomes in patients with aggressive or refractory disease from REVEL : a randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer / Martin Reck, Luis Paz-Ares, Paolo Bidoli, Federico Cappuzzo, Shaker Dakhil, Denis Moro-Sibilot, Hoss… . - 7 S.
  In: Lung cancer, ISSN 1872-8332. 112(2017), S. 181-187
  DOI: 10.1016/j.lungcan.2017.07.038
• Rosell, Rafael: Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF) : an international, multicentre, single-arm, phase 2 trial / Prof Rafael Rosell, MD, Prof Urania Dafni, ScD, Enriqueta Felip, MD, Alessandra Curioni-Fontecedro, … . - 10 S.
  In: The lancet, ISSN 2213-2619. 5(2017), 5, S. 435-444
  DOI: 10.1016/S2213-2600(17)30129-7
• Ostgathe, Christoph: Standard Operating Procedures (SOPs) zur palliativen Versorgung von Patienten im Netzwerk der deutschen Comprehensive Cancer Center (CCCs) / C. Ostgathe, M. Thomas, AG Palliativmedizin im Netzwerk der Comprehensive Cancer Care. - 2 S.
  In: Der Onkologe, ISSN 1433-0415. 23(2017), 3, S. 211-212
  DOI: 10.1007/s00761-017-0201-2
• Sparla, Anika: Reflection of illness and strategies for handling advanced lung cancer : a qualitative analysis in patients and their relatives / Anika Sparla; Sebastian Flach-Vorgang; Matthias Villalobos; Katja Krug; Martina Kamradt; Kadiatou Co… . -
  London: BioMed Central, 2017. - 1 Online-Ressource
  DOI: 10.1186/s12913-017-2110-x
• Pérol, Maurice: Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy / Maurice Pérol, Tudor-Eliade Ciuleanu, Oscar Arrieta, Kumar Prabhash, Konstantinos N. Syrigos, Tuncay… , 2016. - 9 S.
  In: Lung cancer, ISSN 1872-8332. 93(2016), Seite 95-103
  DOI: 10.1016/j.lungcan.2016.01.007
• Alt-Epping, Bernd: Symptoms and needs of head and neck cancer patients at diagnosis of incurability : prevalences, clinical implications, and feasibility of a prospective longitudinal multicenter cohort study / Bernd Alt-Epping, Wiebke Seidel, Jeannette Vogt, Anja Mehnert, Michael Thomas, Birgitt van Oorschot,… , March 30, 2016. - 6 S.
  In: Oncology research and treatment, ISSN 2296-5262. 39(2016), 4, Seite 186-191
  DOI: 10.1159/000445307
• Schütte, Wolfgang: Exonabhängige Subgruppenanalyse der nicht-interventionellen REASON-Studie : PFS und OS beim EGFR-mutierten NSCLC mit Behandlung von Gefitinib versus Chemotherapie / W. Schuette, M. Diete, M. Thomas, W. Eberhardt, F. Griesinger, U. Zirrgiebel, S. Radke, P. Schirmach… , 2016. - 8 S.
  In: Pneumologie, ISSN 1438-8790. 70(2016), 8, Seite 514-521
  DOI: 10.1055/s-0042-109749
• Hörner-Rieber, Juliane: Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC) / Juliane Rieber, Alexander Deeg, Elena Ullrich, Robert Foerster, Marc Bischof, Arne Warth, Philipp A.… , [2016]. - 7 S. : Diagramme
  In: Lung cancer, ISSN 1872-8332. 91(2016), Seite 41-47
  DOI: 10.1016/j.lungcan.2015.11.014
• Sparla, Anika: Individual difficulties and resources : a qualitative analysis in patients with advanced lung cancer and their relatives / Anika Sparla, Sebastian Flach-Vorgang, Matthias Villalobos, Katja Krug, Martina Kamradt, Kadiatou Co… , 3 October 2016. - 9 S.
  In: Patient preference and adherence, ISSN 1177-889X. 10(2016), Seite 2021-2029
  DOI: 10.2147/PPA.S110667
• Berendt, Julia: Integration der Palliativmedizin in die von der Deutschen Krebshilfe e. V. geförderten onkologischen Spitzenzentren / J. Berendt, K. Oechsle, M. Thomas, B. van Oorschot, A. Schmitz, L. Radbruch, S. T. Simon, J. Gärtner… , 22. Januar 2016. - 8 S.
  In: Deutsche medizinische Wochenschrift, ISSN 1439-4413. 141(2016), 02, Seite e16-e23
  DOI: 10.1055/s-0041-106089
• Kreuter, Michael: Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study) / Michael Kreuter MD, Johan Vansteenkiste MD, Jürgen R. Fischer MD, Wilfried E. Eberhardt MD, Heike Za… , 2016. - 9 S.
  In: Journal of thoracic oncology, ISSN 1556-1380. 11(2016), 1, Seite 85-93
  DOI: 10.1016/j.jtho.2015.09.014
• Ammerpohl, Ole: Umfassende Charakterisierung von nicht-kleinzelligem Lungenkarzinom anhand integrierter klinischer und molekularer Analyse : Schlussbericht zum Verwendungsnachweis : Laufzeit des Vorhabens: 01.07.2013-31.12.2016 / Zuwendungsempfänger: Thoraxklinik am Universitätsklinikum Heidelberg, Deutsches Krebsforschungszentr… . -
  Heidelberg: Thoraxklinik am Universitätsklinikum Heidelberg, [2016?]. - 1 Online-Ressource (27 Seiten, 1,86 MB) : Illustrationen, Diagramme
  DOI: 10.2314/GBV:89088952X
• Ammerpohl, Ole: Umfassende Charakterisierung von nicht-kleinzelligem Lungenkarzinom anhand integrierter klinischer und molekularer Analyse : Schlussbericht zum Verwendungsnachweis : Laufzeit des Vorhabens: 01.07.2013-31.12.2016 / Zuwendungsempfänger: Thoraxklinik am Universitätsklinikum Heidelberg, Deutsches Krebsforschungszentr… . -
  Heidelberg: Thoraxklinik am Universitätsklinikum Heidelberg, [2016?]. - 23, 3 ungezählte Blätter : Illustrationen, Diagramm
• Dienemann, Hendrik: Deutsches Zentrum für Lungenforschung (DZL) : Schlussbericht : Förderperiode: 1.10.2011-31.12.2015 / Standort: Translational Lung Research Center Heidelberg, Partner: Thoraxklinik am Universitätsklinik… . -
  Heidelberg: Thoraxklinik am Universitätsklinikum Heidelberg, [2016?]. - 1 Online-Ressource (94 Seiten, 739 KB)
  DOI: 10.2314/GBV:873669398
• Dienemann, Hendrik: Deutsches Zentrum für Lungenforschung (DZL) : Schlussbericht : Förderperiode: 1.10.2011-31.12.2015 / Standort: Translational Lung Research Center Heidelberg, Partner: Thoraxklinik am Universitätsklinik… . -
  Heidelberg: Thoraxklinik am Universitätsklinikum Heidelberg, [2016?]. - 91, 2 ungezählte Blätter
• Marien, Eyra: Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma / Eyra Marien, Michael Meister, Thomas Muley, Teresa Gomez del Pulgar, Rita Derua, Jeffrey M. Spraggin… , February 03, 2016. - 16 S.
  In: OncoTarget, ISSN 1949-2553. 7(2016), 11, Seite 12582-12597
  DOI: 10.18632/oncotarget.7179
• Kim, Dong-Wan: Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1) : updated results from the multicentre, open-label, phase 1 trial / Dong-Wan Kim, Ranee Mehra, Daniel SW Tan, Enriqueta Felip, Laura QM Chow, D Ross Camidge, Johan Vans… , March 10, 2016. - 12 S.
  In: The lancet, ISSN 1474-5488. 17(2016), 4, Seite 452-463
  DOI: 10.1016/S1470-2045(15)00614-2
• Grosch, Heidrun: Thymustumoren : eine klinische Betrachtung / H. Grosch, H. Hoffmann, C.-A. Weis, M. Thomas, 29. Januar 2016. - 16 S.
  In: Der Pathologe, ISSN 1432-1963. 37(2016), 1, Seite 91-106
  DOI: 10.1007/s00292-016-0140-5
• Leichsenring, Jonas: Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma / Jonas Leichsenring, Anna-Lena Volckmar, Nikolaus Magios, Cristiano Manuel Morais de Oliveira, Roland… , 2017. - 7 S.
  In: Genes, chromosomes & cancer, ISSN 1098-2264. 56(2017), 3, Seite 214-220
  DOI: 10.1002/gcc.22427
• Bernhardt, Denise: Nine-year experience : prophylactic cranial irradiation in extensive disease small-cell lung cancer / Denise Bernhardt, Sebastian Adeberg, Farastuk Bozorgmehr, Nils Opfermann, Juliane Hoerner-Rieber, Mi… , 2017. - 5 S.
  In: Clinical lung cancer, ISSN 1938-0690. 18(2017), 4, Seite e267-e271
  DOI: 10.1016/j.cllc.2016.11.012
• Dietz, Steffen: Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients / Steffen Dietz, Uwe Schirmer, Clémentine Mercé, Nikolas von Bubnoff, Edgar Dahl, Michael Meister, Tho… , 16 August 2016
  In: PLOS ONE, ISSN 1932-6203. 11(2016,8) Artikel-Nummer e0161012, 16 Seiten
  DOI: 10.1371/journal.pone.0161012
• Reck, Martin: Necitumumab plus gemcitabine and cisplatin as first-line therapy in patients with stage IV EGFR- expressing squamous non-small-cell lung cancer : German subgroup data from an open-label, randomized controlled phase 3 study (SQUIRE) / Martin Reck, Michael Thomas, Cornelia Kropf-Sanchen, Jörg Mezger, Mark A. Socinski, Henrik Depenbroc… . - 9 S.
  In: Oncology research and treatment, ISSN 2296-5262. 39(2016), 9, S. 539-547
  DOI: 10.1159/000448085
• Riediger, Anja Lisa: Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients / Anja Lisa Riediger, Steffen Dietz, Uwe Schirmer, Michael Meister, Ingrid Heinzmann-Groth, Marc Schne… , 19 September 2016. - 8 S.
  In: Scientific reports, ISSN 2045-2322. 6(2016) Artikel-Nummer 33505, 8 Seiten
  DOI: 10.1038/srep33505
• Schneider, Marc: Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma / Marc A. Schneider, Thomas Muley, Nicolas C. Kahn, Arne Warth, Michael Thomas, Felix J.F. Herth, Hend… , October 04, 2016. - 13 S.
  In: OncoTarget, ISSN 1949-2553. 7(2016), 44, Seite 71285-71297
  DOI: 10.18632/oncotarget.12474
• Steins, Martin: Kleinzelliges Lungenkarzinom / M.B. Steins, C. Henkenberens, M. Bremer, M. Thomas. - 12 S.
  In: Der Onkologe, ISSN 1433-0415. 22(2016), 10, S. 799-810
  DOI: 10.1007/s00761-016-0073-x
• Thomas, Michael: Immune surveillance reactivation to improve overall survival in small cell lung cancer (SCLC) : The randomized IMPULSE study / M. Thomas, R. Carter, S. Ponce Aix, J. Riera-Knorrenschild, A. Navarro Mendivil, M. Domine, J. Kollm…
  In: Annals of oncology, ISSN 1569-8041. 27(2016,Supplement 6) Artikel-Nummer 1432TiP
  DOI: 10.1093/annonc/mdw389.10
• Reck, Martin: Phase III randomized trial of ipilimumab plus etoposide and platinum versus placebo plus etoposide and platinum in extensive-stage small-cell lung cancer / Martin Reck, Alexander Luft, Aleksandra Szczesna, Libor Havel, Sang-We Kim, Wallace Akerley, Maria C… . - 9 S.
  In: Journal of clinical oncology, ISSN 1527-7755. 34(2016), 31, S. 3740-3748
  DOI: 10.1200/JCO.2016.67.6601
• Thatcher, Nicholas: Secondary efficacy results from a phase 3 study comparing efficacy and safety of biosimilar candidate ABP 215 with bevacizumab in patients with non-squamous non-small cell lung cancer (NSCLC) / N. Thatcher, M. Thomas, G. Ostoros, J. Pan, J. Goldschmidt, V. Hanes
  In: Annals of oncology, ISSN 1569-8041. 27(2016,Supplement 6) Artikel-Nummer 1196P, 1 Seite
  DOI: 10.1093/annonc/mdw382.10
• Bernhardt, Denise: Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation / Denise Bernhardt, Farastuk Bozorgmehr, Sebastian Adeberg, Nils Opfermann, Damian von Eiff, Juliane R… , 13 September 2016. - 6 S.
  In: Lung cancer, ISSN 1872-8332. 101(2016), Seite 76-81
  DOI: 10.1016/j.lungcan.2016.09.010
• Volckmar, Anna-Lena: Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient : a case report / Anna-Lena Volckmar, Volker Endris, Farastuk Bozorgmehr, Clemens Lier, Carlota Porcel, Martina Kirchn… , 18 November 2016. - 6 S.
  In: Diagnostic pathology, ISSN 1746-1596. 11(2016), Artikel-ID 133, Seite 1-6
  DOI: 10.1186/s13000-016-0581-4
• Volckmar, Anna-Lena: Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient : a case report / Anna-Lena Volckmar, Volker Endris, Farastuk Bozorgmehr, Clemens Lier, Carlota Porcel, Martina Kirchn… . -
  London: BioMed Central, 18 November 2016. - 1 Online-Ressource (6 Seiten)
  DOI: 10.1186/s13000-016-0581-4
• Wiskemann, Joachim: POSITIVE study : physical exercise program in non-operable lung cancer patients undergoing palliative treatment / Joachim Wiskemann; Simone Hummler; Christina Diepold; Melanie Keil; Ulrich Abel; Karen Steindorf; Ph… . -
  London; Berlin; Heidelberg: BioMed Central; Springer, 2016. - 1 Online-Ressource
  DOI: 10.1186/s12885-016-2561-1
• Watermann, Iris: Improved diagnostics targeting c-MET in non-small cell lung cancer : expression, amplification and activation? / I. Watermann, B. Schmitt, F. Stellmacher, J. Müller, R. Gaber, Ch. Kugler, N. Reinmuth, R.M. Huber, … , 28 July 2018. - 12 S.
  In: Diagnostic pathology, ISSN 1746-1596. 10(2015), Artikel-ID 130, Seite 1-12
  DOI: 10.1186/s13000-015-0362-5
• CancerSys-Verbundprojekt: "LungSys II Systembiologie des Lungenkrebs: dynamische Eigenschaften der frühen Metastasierung und therapeutische Optionen, Teilprojekt D" : Berichtszeitraum: 01/02/2012-31/07/2015 / Zuwendungsempfänger: Thoraxklinik-Heidelberg gGmbH ; Projektleiter Teilprojekt D: Dr. Michael Meiste… . -
  Heidelberg: Thoraxklinik-Heidelberg gGmbH, [2015?]. - 1 Online-Ressource (17 Seiten, 132,89 KB) : Diagramme
  DOI: 10.2314/GBV:880371137
• CancerSys-Verbundprojekt: "LungSys II Systembiologie des Lungenkrebs: dynamische Eigenschaften der frühen Metastasierung und therapeutische Optionen, Teilprojekt D" : Berichtszeitraum: 01/02/2012-31/07/2015 / Zuwendungsempfänger: Thoraxklinik-Heidelberg gGmbH ; Projektleiter Teilprojekt D: Dr. Michael Meiste… . -
  Heidelberg: Thoraxklinik-Heidelberg gGmbH, [2015?]. - 2, 15 Blätter : Diagramme
• Thomas, Michael: Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer / Michael Thomas, Jürgen Fischer, Stefan Andreas, Cornelius Kortsik, Christian Grah, Monika Serke, Mic… , July 2015. - 11 S.
  In: The European respiratory journal, ISSN 1399-3003. 46(2015), 1, Seite 219-229
  DOI: 10.1183/09031936.00229014
• Firnkorn, Daniel: A generic data harmonization process for cross-linked research and network interaction : construction and application for the lung cancer phenotype database of the German Center for Lung Research / D. Firnkorn, M. Ganzinger, T. Muley, M. Thomas, P. Knaup, 2015 Sep 17. - 6 S.
  In: Methods of information in medicine, ISSN 2511-705X. 54(2015), 5, Seite 455-460
  DOI: 10.3414/ME14-02-0030
• Schütte, Wolfgang: EGFR mutation status and first-line treatment in patients with stage III/IV non-small cell lung cancer in Germany : an observational study / Wolfgang Schuette, Peter Schirmacher, Wilfried Ernst Erich Eberhardt, Juergen R. Fischer, J.-Matthia… . - 8 S.
  In: Cancer epidemiology, biomarkers & prevention, ISSN 1538-7755. 24(2015), 8, S. 1254-1261
  DOI: 10.1158/1055-9965.EPI-14-1149
• Ramlau, Rodryg: Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarker / Rodryg Ramlau, Michael Thomas, Silvia Novello, Ruth Plummer, Martin Reck, Tomomi Kaneko, Mike R. Lau… . - 10 S.
  In: Clinical lung cancer, ISSN 1938-0690. 16(2015), 5, S. 348-357
  DOI: 10.1016/j.cllc.2015.01.004
• Grosch, Heidrun: Thymustumoren / H. Grosch, H. Hoffmann, C.-A. Weis, M. Thomas, September 2015. - 15 S.
  In: Der Onkologe, ISSN 1433-0415. 21(2015), 9, Seite 859-873
  DOI: 10.1007/s00761-015-3025-y
• Marien, Eyra: Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles / Eyra Marien, Michael Meister, Thomas Muley, Steffen Fieuws, Sergio Bordel, Rita Derua, Jeffrey Sprag… . - 10 S.
  In: International journal of cancer, ISSN 1097-0215. 137(2015), 7, S. 1539-1548
  DOI: 10.1002/ijc.29517
• Sklenárová, Halina: When do we need to care about the caregiver? : Supportive care needs, anxiety, and depression among informal caregivers of patients with cancer and cancer survivors / Halina Sklenarova, MA; Arne Krümpelmann, MD candidate; Markus W. Haun, MD; Hans-Christoph Friederich… , 2015. - 7 S.
  In: Cancer, ISSN 1097-0142. 121(2015), 9, Seite 1513-1519
  DOI: 10.1002/cncr.29223
• Sklenárová, Halina: Psychometric evaluation of the German version of the supportive care needs survey for partners and caregivers (SCNS-P&C-G) of cancer patients / H. Sklenarova, MA, Dipl.-Psych., Research Follow, Department of General Internal Medicine &Psychosom… , 2015. - 14 S.
  In: European journal of cancer care, ISSN 1365-2354. 24(2015), 6, Seite 884-897
  DOI: 10.1111/ecc.12325
• Hörner-Rieber, Juliane: Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas / Juliane Rieber; Julian Schmitt; Arne Warth; Thomas Muley; Jutta Kappes; Florian Eichhorn; Hans Hoffm… . -
  London: BioMed Central, 2016. - 1 Online-Ressource (8 Seiten)
  DOI: 10.1186/s40001-015-0158-9
• Hauswald, Henrik: Ion therapy within the trimodal management of superior sulcus tumors : the INKA trial / Henrik Hauswald; Stefan Rieken; Hendrik C. Dienemann; Michael Thomas; Meinhard Kieser; Jürgen Debus … . -
  London: BioMed Central, 2015. - 1 Online-Ressource (5 Seiten)
  DOI: 10.1186/s12885-015-1163-7
• Schneider, Marc: Glycodelin - a new biomarker with immunomodulatory functions in non-small cell lung cancer / Marc A. Schneider, Martin Granzow, Arne Warth, Philipp A. Schnabel, Michael Thomas, Felix J. F. Hert… . - 12 S.
  In: Clinical cancer research, ISSN 1557-3265. 21(2015), 15, S. 3529-3540
  DOI: 10.1158/1078-0432.CCR-14-2464
• Schneider, Marc: The pregnancy associated protein glycodelin as a follow-up biomarker in a male non-small cell lung cancer patient / Marc A. Schneider, Nicolas C. Kahn, Michael Thomas, Felix J. F. Herth, Thomas Muley, Claus P. Heusse… , 11 September 2015. - 4 S.
  In: Cancer Treatment Communications, ISSN 2213-0896. 4(2015), Seite 139-142
  DOI: 10.1016/j.ctrc.2015.09.005
• Hörner-Rieber, Juliane: Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas / Juliane Rieber; Julian Schmitt; Arne Warth; Thomas Muley; Jutta Kappes; Florian Eichhorn; Hans Hoffm… , 2015. - 8 S.
  In: European journal of medical research, ISSN 2047-783X. 20(2015) Artikel-Nummer. 64, 8 Seiten
  DOI: 10.1186/s40001-015-0158-9
• Sachpekidis, Christos: Combined use of 18 F-FDG and 18 F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy : a dynamic PET/CT study / Christos Sachpekidis; Christian Thieke; Vasileios Askoxylakis; Nils H. Nicolay; Peter E. Huber; Mich… , 2015. - 16 S.
  In: American journal of nuclear medicine and molecular imaging, ISSN 2160-8407. 5(2015), 2, Seite 127-142
• Hauswald, Henrik: Ion therapy within the trimodal management of superior sulcus tumors : the INKA trial / Henrik Hauswald; Stefan Rieken; Hendrik C Dienemann; Michael Thomas; Meinhard Kieser; Jürgen Debus a… , 2015
  In: BMC cancer, ISSN 1471-2407. 15(2015) Artikel-Nr. 192, 5 S.
  DOI: 10.1186/s12885-015-1163-7
• Steins, Martin: Erlotinib / M. Steins, M. Thomas, M. Geissler, 23 April 2014. - 15 S.
  In: Small molecules in oncology. (2014), Seite 109-123
  DOI: 10.1007/978-3-642-54490-3_6
• Shaw, Alice T.: Ceritinib in ALK-rearranged non-small-cell lung cancer / Alice T. Shaw, Dong-Wan Kim, Ranee Mehra, Daniel S.W. Tan, Enriqueta Felip, Laura Q.M. Chow, D. Ross… , 2014 March 27. - 9 S.
  In: The New England journal of medicine, ISSN 1533-4406. 370(2014), 13, Seite 1189-1197
  DOI: 10.1056/NEJMoa1311107
• Heigener, David: Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer / D.F. Heigener, K.M. Deppermann, J. v. Pawel, J.R. Fischer, C. Kortsik, S. Bohnet, M. v. Eiff, W. Koe… , 26 January 2014. - 5 S.
  In: Lung cancer, ISSN 1872-8332. 84(2014), 1, Seite 62-66
  DOI: 10.1016/j.lungcan.2014.01.024
• Reinmuth, Niels: Insulin-like growth factor 1 pathway mutations and protein expression in resected non-small cell lung cancer / Niels Reinmuth MD, PhD, Sebastian Kloos, Arne Warth MD, Angela Risch PhD, Thomas Muley PhD, Hans Hof… , 30 January 2014. - 7 S.
  In: Human pathology, ISSN 1532-8392. 45(2014), 6, Seite 1162-1168
  DOI: 10.1016/j.humpath.2014.01.010
• Reinmuth, Niels: Characteristics of lung cancer after a previous malignancy / Niels Reinmuth, Patrick Stumpf, Andreas Stumpf, Thomas Muley, Sonja Kobinger, Hans Hoffmann, Felix J… , 5 March 2014. - 8 S.
  In: Respiratory medicine, ISSN 1532-3064. 108(2014), 6, Seite 910-917
  DOI: 10.1016/j.rmed.2014.02.015
• Thomas, Michael: Nichtkleinzellige Lungenkarzinome / M. Thomas, M. Bamberg, 17. August 2014. - 3 S.
  In: Der Onkologe, ISSN 1433-0415. 20(2014), 10, Seite 930-932
  DOI: 10.1007/s00761-013-2566-1
• Gridelli, Cesare: Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study / Cesare Gridelli, Filippo de Marinis, Michael Thomas, Kumar Prabhash, Claude El Kouri, Fiona Blackhal… . - 7 S.
  In: Journal of thoracic oncology, ISSN 1556-1380. 9(2014), 7, S. 991-997
  DOI: 10.1097/JTO.0000000000000207
• Haun, Markus W.: Early palliative care for improving quality of life and survival time in adults with advanced cancer / Haun MW, Estel S, Rücker G, Friederich HC, Thomas M, Hartmann M, 26 May 2014. - 11 S.
  In: The Cochrane database of systematic reviews, ISSN 1469-493X. (2014,5) Artikel-Nummer CD011129, 11 Seiten
  DOI: 10.1002/14651858.CD011129
• Garon, Edward B.: Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL) : a multicentre, double-blind, randomised phase 3 trial / Edward B. Garon, Tudor-Eliade Ciuleanu, Oscar Arrieta, Kumar Prabhash, Konstantinos N. Syrigos, Tunc… . - 9 S.
  In: The lancet, ISSN 1474-547X. 384(2014), 9944, S. 665-673
  DOI: 10.1016/S0140-6736(14)60845-X
• Sebastian, Martin: Molekulargenetische Untersuchungen bei fortgeschrittenem nicht-kleinzelligem Lungenkarzinom : praktische Relevanz / M. Sebastian, N. Niederle, M. Thomas, M. Reck, A. Schmittel, B. Fischer, T. Overbeck, A. Gröschel, M… . - 5 S.
  In: Deutsche medizinische Wochenschrift, ISSN 1439-4413. 139(2014), 41, S. 2096-2100
  DOI: 10.1055/s-0034-1387294
• Warth, Arne: EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinornas : patient outcome, interplay with morphology and immunophenotype / Arne Warth, Roland Penzel, Heike Lindenmaier, Regine Brandt, Albrecht Stenzinger, Esther Herpel, Ben… , 2014. - 12 S.
  In: The European respiratory journal, ISSN 1399-3003. 43(2014), 3, Seite 872-883
  DOI: 10.1183/09031936.00018013
• Wiskemann, Lea Josefine: Exercise in patients with non-small cell lung cancer / Kuehr, Lea; Wiskemann, Joachim; Abel, Ulrich; Ulrich, Cornelia; Hummler, Simone; Thomas, Michael, April 2014. - 8 S.
  In: Medicine and science in sports and exercise, ISSN 1530-0315. 46(2014), 4, Seite 656-663
  DOI: 10.1249/MSS.0000000000000158
• Blum, Thorsten G.: The European initiative for quality management in lung cancer care / Torsten G. Blum, Anna Rich, David Baldwin, Paul Beckett, Dirk De Ruysscher, Corinne Faivre-Finn, Min… . - 24 S.
  In: The European respiratory journal, ISSN 1399-3003. 43(2014), 5, S. 1254-1277
  DOI: 10.1183/09031936.00106913
• Pujol, Jean-Louis: Long-term and low-grade safety results of a phase III study (PARAMOUNT) : maintenance Pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with Pemetrexed plus Cisplatin for advanced nonsquamous non-small-cell lung cancer / Jean-Louis Pujol, Luis Paz-Ares, Filippo de Marinis, Mircea Dediu, Michael Thomas, Paolo Bidoli, Jes… . - 8 S.
  In: Clinical lung cancer, ISSN 1938-0690. 15(2014), 6, S. 418-425
  DOI: 10.1016/j.cllc.2014.06.007
• Haun, Markus W.: Depression, anxiety and disease-related distress in couples affected by advanced lung cancer / Markus W. Haun, Halina Sklenarova, Matthias Villalobos, Michael Thomas, Anette Brechtel, Bernd Löwe,… , 2014. - 7 S.
  In: Lung cancer, ISSN 1872-8332. 86(2014), 2, Seite 274-280
  DOI: 10.1016/j.lungcan.2014.09.009
• Hülsmann, Helen Jennifer: Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinib / Helen J. Hülsmann, Jana Rolff, Christian Bender, Mostafa Jarahian, Ulrike Korf, Ralf Herwig, Holger … , 2014. - 7 S.
  In: Lung cancer, ISSN 1872-8332. 86(2014), 2, Seite 151-157
  DOI: 10.1016/j.lungcan.2014.09.001
• Warth, Arne: Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role / A. Warth, J. Cortis, A. Soltermann, M. Meister, J. Budczies, A. Stenzinger, B. Goeppert, M. Thomas, … . - 8 S.
  In: British journal of cancer, ISSN 1532-1827. 111(2014), 6, S. 1222-1229
  DOI: 10.1038/bjc.2014.402
• Askoxylakis, Vasileios: Trimodal therapy for stage III-N2 non-small-cell lung carcinoma : a single center retrospective analysis / Vasileios Askoxylakis, Judith Tanner, Jutta Kappes, Hans Hoffmann, Nils H. Nicolay, Harald Rief, Jue…
  In: BMC cancer, ISSN 1471-2407. 14(2014) Artikel-Nr. 572, 10 S.
  DOI: 10.1186/1471-2407-14-572
• Scagliotti, Giorgio V.: Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment : a cross-trial comparison of two phase III trials / G.V. Scagliotti, C. Gridelli, F. de Marinis, M. Thomas, M. Dediu, J.-L. Pujol, C. Manegold, B. San A… , 2014. - 7 S.
  In: Lung cancer, ISSN 1872-8332. 85(2014), 3, Seite 408-414
  DOI: 10.1016/j.lungcan.2014.07.005
• Hummler, Simone: Physical performance and psychosocial status in lung cancer patients : results from a pilot study / Simone Hummler; Michael Thomas, Belinda Hoffmann; Philipp Gärtner, Martin Zoz; Gerhard Huber; Cornel… , 2014. - 6 S.
  In: Oncology research and treatment, ISSN 2296-5262. 37(2014), 1/2, Seite 36-41
  DOI: 10.1159/000358157
• Haun, Markus W.: Assessing patient-caregiver communication in cancer : psychometric validation of the Cancer Communication Assessment Tool (CCAT-PF) in a German sample / Markus W. Haun; Halina Sklenarova; Eva C. Winkler; Johannes Huber; Michael Thomas ... Michael Woll;… , 2014. - 6 S.
  In: Supportive care in cancer, ISSN 1433-7339. 22(2014), 9, Seite 2473-2478
  DOI: 10.1007/s00520-014-2241-0
• Eberhardt, Wilfried E. E.: Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancer / Eberhardt, Wilfried E. E. ...Thomas, Michael ..., 2014. - 12 S.
  In: Investigational new drugs, ISSN 1573-0646. 32(2014), 1, Seite 123-134
  DOI: 10.1007/s10637-013-9958-3
• Carrato Mena, Alfredo: Clinical management patterns and treatment outcomes in patients with non-small cell lung cancer (NSCLC) across Europe : EPICLIN-Lung study / Carrato, A. ... Thomas, M. ..., 2014. - 15 S.
  In: Current medical research and opinion, ISSN 1473-4877. 30(2014), 3, Seite 447-461
  DOI: 10.1185/03007995.2013.860372
• Vergnenègre, Alain: Real-world healthcare resource utilization in a European non-small cell lung cancer population : the EPICLIN-Lung study / A. Vergnenègre, A. Carrato, M. Thomas, C. Jernigan, J. Medina, G. Cruciani. - 8 S.
  In: Current medical research and opinion, ISSN 1473-4877. 30(2014), 3, S. 463-470
  DOI: 10.1185/03007995.2013.860373
• Shaw, Alice T.: Crizotinib versus chemotherapy in advanced ALK-positive lung cancer / Alice T. Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De … , June 20, 2013. - 10 S.
  In: The New England journal of medicine, ISSN 1533-4406. 368(2013) vom: 20. Juni, Seite 2385-2394
  DOI: 10.1056/NEJMoa1214886
• Reinmuth, Niels: Treatment and outcome of patients with metastatic NSCLC : a retrospective institution analysis of 493 patients / Niels Reinmuth, Nadine Payer, Thomas Muley, Hans Hoffmann, Felix Jf Herth, Matthias Villalobos and M… , 18 December 2013. - 9 S.
  In: Respiratory research, ISSN 1465-993X. 14(2013), Artikel-ID 139, Seite 1-9
  DOI: 10.1186/1465-9921-14-139
• Huber, Rudolf M.: Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer / Rudolf M. Huber, Martin Reck and Michael Thomas, September 30, 2013. - 15 S.
  In: The European respiratory journal, ISSN 1399-3003. 42(2013), 4, Seite 1119-1133
  DOI: 10.1183/09031936.00143112
• Muley, Thomas: Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancer / Thomas Muley, PhD, Hendrik Dienemann, MD, PhD, Felix JF Herth, MD, PhD, Michael Thomas, MD, PhD, Mic… , 2013. - 5 S.
  In: Journal of thoracic oncology, ISSN 1556-1380. 8(2013), 7, Seite 947-951
  DOI: 10.1097/JTO.0b013e31828f696b
• Gottschling, Sandra: Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer / Sandra Gottschling, Katrin Jensen, Felix J.F. Herth, Michael Thomas, Philipp A. Schnabel and Esther … , March 11, 2013. - 10 S.
  In: Anticancer research, ISSN 1791-7530. 33(2013), 3, Seite 981-990
• Dinkel, Julien: Inter-observer reproducibility of semi-automatic tumor diameter measurement and volumetric analysis in patients with lung cancer / J. Dinkel, O. Khalilzadeh, C. Hintze, M. Fabel, M. Puderbach, M. Eichinger, H.-P. Schlemmer, M. Thor… , 8 August 2013. - 7 S.
  In: Lung cancer, ISSN 1872-8332. 82(2013), 1, Seite 76-82
  DOI: 10.1016/j.lungcan.2013.07.006
• Kreuter, Michael: Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer / Michael Kreuter, Johan Vansteenkiste, Felix J.F. Herth, Jürgen R. Fischer, Wilfried Eberhardt, Ivan … , 2014. - 7 S.
  In: Respiration, ISSN 1423-0356. 87(2014), 3, Seite 204-210
  DOI: 10.1159/000355361
• Griesinger, Frank: Vorwort / Frank Griesinger, Rudolf M. Huber, Michael Thomas, Martin Wolf. - 1 S.
  In: Onkologie, ISSN 1423-0240. 36(2013), Suppl. 6, S. 1-1
  DOI: 10.1159/000353713
• Reinmuth, Niels: Characteristics and outcome of patients with second primary lung cancer / Niels Reinmuth, Andreas Stumpf, Patrick Stumpf, Thomas Muley, Sonja Kobinger, Hans Hoffmann, Felix J… , 2013. - 9 S.
  In: The European respiratory journal, ISSN 1399-3003. 42(2013), 6, Seite 1668-1676
  DOI: 10.1183/09031936.00022512
• Gottschling, Sandra: Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis / Sandra Gottschling, Katrin Jensen, Arne Warth, Felix J. F. Herth, Michael Thomas, Philipp A. Schnabe… , 2013. - 8 S.
  In: The European respiratory journal, ISSN 1399-3003. 41(2013), 3, Seite 656-663
  DOI: 10.1183/09031936.00225711
• Pfannschmidt, Joachim: Surgical intervention for pulmonary metastases / Joachim Pfannschmidt, Gerlinde Egerer, Marc Bischof, Michael Thomas, Hendrik Dienemann, 2012. - 7 S.
  In: Deutsches Ärzteblatt international, ISSN 1866-0452. 109(2012), 40, Seite 645-51
• Warth, Arne: The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival / Arne Warth, Thomas Muley, Michael Meister, Albrecht Stenzinger, Michael Thomas, Peter Schirmacher, P… , May 01, 2012. - 9 S.
  In: Journal of clinical oncology, ISSN 1527-7755. 30(2012), 13, Seite 1438-1446
  DOI: 10.1200/JCO.2011.37.2185
• Warth, Arne: Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies / Arne Warth, Roland Penzel, Regine Brandt, Christine Sers, Jürgen R. Fischer, Michael Thomas, Felix J… . - 8 S.
  In: Virchows Archiv, ISSN 1432-2307. 460(2012), 4, S. 407-414
  DOI: 10.1007/s00428-012-1219-x
• Warth, Arne: Clonality of multifocal nonsmall cell lung cancer : implications for staging and therapy / Arne Warth, Stephan Macher-Goeppinger, Thomas Muley, Michael Thomas, Hans Hoffmann, Philipp A. Schna… , 2012. - 6 S.
  In: The European respiratory journal, ISSN 1399-3003. 39(2012), 6, Seite 1437-1442
  DOI: 10.1183/09031936.00105911
• Scagliotti, Giorgio V.: Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer : a phase III trial / Giorgio V. Scagliotti, Maciej Krzakowski, Aleksandra Szczesna, Janos Strausz, Anatoly Makhson, Marti… , May 7, 2012. - 9 S.
  In: Journal of clinical oncology, ISSN 1527-7755. 30(2012), 17, Seite 2070-2078
  DOI: 10.1200/JCO.2011.39.2993
• Brugger, Wolfram: EGFR-TKI resistant non-small cell lung cancer (NSCLC) : new developments and implications for future treatment / Wolfram Brugger, Michael Thomas. - 7 S.
  In: Lung cancer, ISSN 1872-8332. 77(2012), 1, S. 2-8
  DOI: 10.1016/j.lungcan.2011.12.014
• Paz-Ares, Luis: Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT) : a double-blind, phase 3, randomised controlled trial / Luis Paz-Ares, Filippo de Marinis, Mircea Dediu, Michael Thomas, Jean-Louis Pujol, Paolo Bidoli, Oli… . - 9 S.
  In: The lancet, ISSN 1474-5488. 13(2012), 3, S. 247-255
  DOI: 10.1016/S1470-2045(12)70063-3
• Herpel, Esther: Assessment of thymidylate synthase expression in biopsy specimens and corresponding resection specimens of non-small-cell lung cancer / Esther Herpel, Philipp A. Schnabel, Martin Steins, Hendrik Dienemann, Felix J. F. Herth, Michael Tho… . - 8 S.
  In: Histopathology, ISSN 1365-2559. 61(2012), 3, S. 465-472
  DOI: 10.1111/j.1365-2559.2012.04248.x
• Gottschling, Sandra: The gefitinib long-term responder (LTR) - a cancer stem-like cell story? : Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP) / Sandra Gottschling, Esther Herpel, Wilfried E. E. Eberhardt, David F. Heigener, Jürgen R. Fischer, C… , July 2012. - 9 S.
  In: Lung cancer, ISSN 1872-8332. 77(2012), 1, Seite 183-191
  DOI: 10.1016/j.lungcan.2012.03.003
• Swartman, Benedict: Radiochemotherapie beim nichtkleinzelligen Bronchialkarzinom / B. Swartman, J. Hausmanns, F. Zwicker, M. Thomas, K. Herfarth, C.P. Heußel, 6. August 2011. - 6 S.
  In: Medizinische Klinik, ISSN 1615-6722. 106(2011), 3, Seite 212-217
  DOI: 10.1007/s00063-011-0053-2
• Knöfel, Lena Franziska: Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer / Lena Franziska Knoefel, Gisela Werle-Schneider, Heike Dally, Phillip Johannes Müller, Lutz Edler, He… , 2011. - 7 S.
  In: Journal of thoracic oncology, ISSN 1556-1380. 6(2011), 1, Seite 183-189
  DOI: 10.1097/JTO.0b013e3181f8a20e
• Herpel, Esther: The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer / Esther Herpel, Katrin Jensen, Thomas Muley, Arne Warth, Philipp A. Schnabel, Michael Meister, Felix … , [December 2011]. - 10 S. : Illustrationen
  In: Anticancer research, ISSN 1791-7530. 31(2011), 12 vom: Dez., Seite 4491-4500
• Heigener, David: Palliativmedizin in der Pneumologie oder Pneumologie in der Palliativmedizin : eine Stellungnahme / D. Heigener, C. Bausewein, O. Karg, S. Rosseau, S.T. Simon, M. Thomas, H. Magnussen, [2011]. - 3 S.
  In: Deutsche medizinische Wochenschrift, ISSN 1439-4413. 136(2011), 13, Seite 648-650
  DOI: 10.1055/s-0031-1274558
• Natale, Ronald B.: Phase III trial of vandetanib compared with erlotinib in patients with previously trreated advanced non-small-cell lung cancer / Ronald B. Natale, Sumitra Thongprasert, F. Anthony Greco, Michael Thomas, Chun-Ming Tsai, Patrapim S… , March 10 2011. - 8 S.
  In: Journal of clinical oncology, ISSN 1527-7755. 29(2011), 8, Seite 1059-1066
  DOI: 10.1200/JCO.2010.28.5981
• Jensen, Alexandra: Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab : the Near trial / Alexandra D. Jensen, Marc W. Münter, Helge G. Bischoff, Renate Haselmann, Uwe Haberkorn, Peter E. Hu… , 24 January 2011. - 9 S.
  In: Cancer, ISSN 1097-0142. 117(2011), 13, Seite 2986-2994
  DOI: 10.1002/cncr.25888
• Gottschling, Sandra: KRAS-mutation positive, metastatic tonsil carcinoma with cancer stem-like cell features and long-term response to gefitinib : a case report and review of the literature / Sandra Gottschling, Roland Penzel, Tanja Pelz, Esther Herpel and Philipp A. Schnabel, Gerhard Dyckho… , May 09, 2011
  In: Journal of clinical oncology, ISSN 1527-7755. 29(2011), 21, Seite e616-e619
  DOI: 10.1200/JCO.2011.34.5892
• Gottschling, Sandra: KRAS-mutation positive, metastatic tonsil carcinoma with cancer stem-like cell features and long-term response to gefitinib : a case report and review of the literature / Sandra Gottschling, Roland Penzel, Tanja Pelz, Esther Herpel and Philipp A. Schnabel, Gerhard Dyckho… , 2011. - 4 S.
  In: Journal of clinical oncology, ISSN 0732-183X. 29(2011), 21, Seite e616-619
• Herpel, Esther: The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer / $hEsther Herpel, Katrin Jensen, Thomas Muley, Arne Warth, Philipp A. Schnabel, Michael Meister, Feli… , 2011. - 10 S.
  In: Anticancer research, ISSN 0250-7005. 31(2011), 12, Seite 4491-5000
• Zatloukal, Petr: A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease / P. Zatloukal, F. Cardenal, A. Szczesna, V. Gorbunova, V. Moiseyenko, X. Zhang, L. Cisar, J. -C. Sori… , September 2010. - 7 S. : 1 Diagramm
  In: Annals of oncology, ISSN 1569-8041. 21(2010), 9 vom: Sept., Seite 1810-1816
  DOI: 10.1093/annonc/mdq036
• Steins, Martin: Targeting the epidermal growth factor receptor in non-small cell lung cancer / Martin B. Steins, Niels Reinmuth, Helge Bischoff, Markus Kindermann, Michael Thomas, November 26 2010. - 6 S.
  In: Onkologie, ISSN 1423-0240. 33(2010), 12, Seite 704-709
  DOI: 10.1159/000322214
• Gatzemeier, Ulrich: Vorwort / Ulrich Gatzemeier, Frank Griesinger, Rudolf M. Huber, Michael Thomas, May 14, 2010. - 1 S.
  In: Onkologie, ISSN 1423-0240. 33(2010), Suppl. 5, Seite 1
  DOI: 10.1159/000313970
• Debus, Jürgen: Grenzlinien der Kuration / Jürgen Debus, Wilfried Eberhardt, Hans Hoffmann, Bernward Passlick, Christian Rübe, Michael Thomas, May 14, 2010. - 9 S.
  In: Onkologie, ISSN 1423-0240. 33(2010), Suppl. 5, Seite 12-20
  DOI: 10.1159/000313972
• Schiller, Joan H.: Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer / Joan H. Schiller, Joachim von Pawel, Philipp Schütt, Rafat H. Ansari, Michael Thomas, Mansoor Saleh,… , 2010. - 9 S.
  In: Journal of thoracic oncology, ISSN 1556-1380. 5(2010), 12 vom: Dez., Seite 1977-1985
  DOI: 10.1097/JTO.0b013e3181f4a5c9
• Reinmuth, Niels: Current data on predictive markers for anti-angiogenic therapy in thoracic tumours / N. Reinmuth, M. Thomas, M. Meister, P.A. Schnabel and M. Kreuter, September 30, 2010. - 10 S.
  In: The European respiratory journal, ISSN 1399-3003. 36(2010), 4 vom: Sept., Seite 915-924
  DOI: 10.1183/09031936.00074009
• Kreuter, Michael: Trial on refinement of early stage non-small cell lung cancer : adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol ; study protocol / Michael Kreuter, Johan Vansteenkiste, Frank Griesinger, Hans Hoffmann, Hendrik Dienemann, Paul De Le… , 2007. - 12 S.
  In: BMC cancer, ISSN 1471-2407. 7(2007) Artikel-Nummer 77, 12 Seiten

IDs

GND:	1054438781

Links

Thomas, Michael in ...

• Deutsche Nationalbibliothek (DNB)
• Virtual International Authority File (VIAF)

Export publication list

• RIS (Endnote)
• BibTeX
• RDF
• MODS
• P°NK (ExIni)

heiBIB

Please contact biblio@ub.uni-heidelberg.de in case of any errors or omissions.

Information concerning heiBIB (including embedding the publication list in existing websites).